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5ABSTRACT
Background
Clinical decisions in prehospital critical care are often based on limited information 
about the patient’s medical history and the events preceding the acute illness. In 
addition to physical examination, point-of-care (POC) laboratory diagnostics can 
provide information for decision-making. Unfortunately, obtaining blood samples 
IRU 32& DQDO\VLV IURP FULWLFDOO\ LOO SDWLHQWV FDQ VRPHWLPHV EH GLɤFXOW WKXV
diminishing the usefulness of POC analyses in prehospital critical care.
,QWUDRVVHRXV,2DFFHVV LVXVHGDVDQRSWLRQDOYDVFXODUURXWH IRUÀXLGDQG
PHGLFDWLRQDGPLQLVWUDWLRQIRUHPHUJHQF\SDWLHQWVZKHQGLɤFXOWLHVZLWKYHQRXV
access are encountered. Using IO access as a source of POC laboratory samples 
is interesting; however, evidence regarding the feasibility and agreement of these 
samples with arterial and venous samples is scarce. We therefore designed a series 
of studies to obtain more information on the POC analysis of IO samples.
Materials and methods
First, we performed a systematic literature review of the studies addressing the 
POC analyses of IO samples (Study I). We included all publications using POC or 
conventional laboratory methods to compare IO samples with venous or arterial 
samples for the parameters relevant to emergency care.
Second, we performed an observational study within 31 healthy volunteers 
(Study II). We evaluated the feasibility of IO analyses with an i-STAT® POC device 
and the agreement of IO values with arterial and venous values. The agreement was 
evaluated using the Bland–Altman method. In addition, we examined the necessity 
to draw waste blood before taking the actual IO sample for POC analysis.
Third, we studied the usability of IO POC values under unstable haemodynamic 
conditions with an experimental porcine (n = 23) resuscitation model (Study III). 
The model simulated a real-life course of cardiac arrest (CA) and cardiopulmonary 
resuscitation (CPR). Four repeated samples were simultaneously drawn from the 
IO access, artery and central vein during CA and CPR, and were instantly analysed 
with an i-STAT® POC device. The laboratory values were plotted as a function of 
time to demonstrate their development during CA and CPR. The arterial, venous 
and IO samples which were taken during CPR were compared with the arterial 
baseline samples to observe how they resemble the pre-arrest state.
Last, in an observational study, we analysed the agreement between IO and 
arterial samples obtained from 35 critically ill prehospital patients, using the 
6ABSTRACT
Bland–Altman method (Study IV). Moreover, we administered a questionnaire 
about acceptable biases in clinical practice to 16 experienced emergency physicians 
and compared our results with their responses.
Results
The 27 reviewed studies had heterogeneous populations: healthy volunteers, 
haemodynamically stable and unstable animals, adult and paediatric haematologic 
patients, and emergency patients. Only three of these studies followed the 
recommended guidelines for method comparison studies. The sample sizes were 
relatively small (n ±DQGWKHSRSXODWLRQVZHUHKHWHURJHQHRXVLQWKHVHWKUHH
studies precluding the combining of results for meta-analysis. However, in IO 
samples, potassium values were generally higher than in arterial or venous samples.
In the observational studies, we found that the POC analyses of IO samples were 
often feasible. Higher failure rates were associated with higher age. Agreement of 
IO values with arterial values appeared acceptable for base excess, pH, standard 
bicarbonate, lactate, glucose, ionised calcium and sodium within healthy volunteers 
and critically ill emergency patients. Potassium values from IO samples were 
systematically higher than arterial and venous values (biases 1.8–2.2 mmol/l). 
Agreement within haemoglobin and haematocrit measurements showed very large 
variety (95% limits of agreement in the bias of haemoglobin up to 95 g/l). However, 
the sample sizes were too small to unequivocally prove the agreement.
Using the resuscitation model, we discovered that IO, arterial and venous values 
FKDQJHGGLɣHUHQWO\IURPRQHDQRWKHUGXULQJ&$DQG&35$FLGDHPLDZDVGHWHFWDEOH
LQ,2VDPSOHVGXULQJXQWUHDWHGYHQWULFXODU¿EULOODWLRQEXWLQDUWHULDOVDPSOHVWKH
acidaemia was evident only after the initiation of CPR. The average potassium values 
during CPR from IO, arterial and venous samples were 4.4, 3.3, and 2.8 mmol/l 
higher than the pre-arrest arterial values, respectively.
Conclusions
When obtaining vascular access is challenging, IO access can be used for emergency 
POC analyses; however, the results of IO POC analyses should be interpreted with 
care. Waste blood does not need to be taken before the sample. POC analyses of IO 
samples may fail for older patients. In general, potassium values from IO samples 
are usually higher than those from arterial and venous samples, haemoglobin and 
haematocrit measurements from IO access are not reliable, and partial pressure 
measurements of oxygen and carbon dioxide from IO samples represent venous 
rather than arterial values.
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AaDCO2  DUWHULRDOYHRODUFDUERQGLR[LGHGLɣHUHQFH
ABG  arterial blood gases
ALS  advanced life support
AMI  acute myocardial infarction
art  arterial
BE  base excess
BP  blood pressure
CA  cardiac arrest
CCU  coronary care unit
&,  FRQ¿GHQFHLQWHUYDO
CLSI  Clinical and Laboratory Standards Institute
CO2  carbon dioxide
CPR  cardiopulmonary resuscitation
CV  central venous
d  GLɣHUHQFH
EMS  emergency medical service
ED  emergency department
ERC  European Resuscitation Council
g  gram
GCS  Glasgow Coma Score
*)$3  SODVPDJOLDO¿EULOODU\DFLGLFSURWHLQ
h  hour
Hb  haemoglobin
HCOɜ  standard bicarbonate
Hct  haematocrit
HEMS  helicopter emergency medical service
iCa  ionised calcium
,&&  LQWUDFODVVFRUUHODWLRQFRHɤFLHQW
ICH  intracerebral haemorrhage
INR  international normalised ratio
IO  intraosseous
IQR  interquartile range
IV  intravenous
K  potassium
kg  kilogram
kPa  kilopascal
l  litre
9LOA  limits of agreement
MeSH  Medical Subject Headings
ml  millilitre
mmHg  millimetre of mercury
mmol/l  millimoles per litre
n  sample size
Na  sodium
ng  nanogram
OHCA  out-of-hospital cardiac arrest
paO2  partial pressure of arterial oxygen
pCO2  partial pressure of carbon dioxide
pH  pH (measure of acidity and basicity of an aqueous solution)
pO2  partial pressure of oxygen
POC  point-of-care
POCT  point-of-care testing
ROSC  return of spontaneous circulation
SD  standard deviation
SE  standard error
SpO2  peripheral oxygen saturation
9)  YHQWULFXODU¿EULOODWLRQ

1 INTRODUCTION
An increasing number of critically ill patients receive advanced emergency care 
before arriving at the hospital owing to the progress in prehospital emergency care 
during the past decades. The progress is seen in terms of not only the training and 
skills of the emergency care providers but also the equipment. The methods and 
devices commonly used inside hospitals for examining, monitoring and treating 
the patients have developed to meet the needs of the prehospital environment.
New methods are eagerly adopted in prehospital systems. Emergency care 
providers are generally highly educated and motivated and are often forced to make 
decisions under challenging conditions with very limited information. Adjuncts for 
decision-making can reduce uncertainty and support the providers to give better care 
for the emergency patients. However, all new methods and devices must be properly 
validated before implementing them in the emergency system. The decision to 
VWDUWXVLQJDQHZPHWKRGVKRXOGEHEDVHGRQHYLGHQFHEDVHGVFLHQWL¿FLQIRUPDWLRQ
EHFDXVHTXHVWLRQLQJWKHMXVWL¿FDWLRQRIDQDOUHDG\HVWDEOLVKHGPHWKRGLVGLɤFXOW
Intraosseous (IO) access is used in prehospital and in-hospital care as an 
DOWHUQDWLYHYDVFXODUDFFHVVZKHQGLɤFXOWLHV LQHVWDEOLVKLQJDQLQWUDYHQRXV,9
access are encountered, such as among drug abusers, burn patients, small children 
or patients in cold environments or in shock (1,2). Currently, IO access is used for 
DGPLQLVWHULQJÀXLGVDQGPHGLFDWLRQ
Likewise, point-of-care (POC) laboratory analyses are used in prehospital 
care and emergency departments (ED) to save time or to compensate for missing 
laboratory facilities (3,4). Resuscitation guidelines suggest screening and correcting 
the reversible causes of cardiac arrest (CA) during cardiopulmonary resuscitation 
(CPR), for example, using laboratory analyses (5,6). Information about pre-arrest 
pathologies, such as electrolyte disorders, acid–base balance disturbances or 
bleeding, could be obtained via POC laboratory analyses. Obtaining a blood sample 
IURPWKHDUWHU\RUYHLQRIDFULWLFDOO\LOOSDWLHQWFDQVRPHWLPHVEHGLɤFXOWRZLQJWR
vasoconstriction or cold environment. A question of whether IO access could be 
used as a source of emergency laboratory samples in such cases has arisen.
Whether IO samples better resemble arterial, venous or capillary blood is not 
VHOIHYLGHQW/LNHZLVH WKH LQÀXHQFHRIEOHHGLQJDQGK\SRYRODHPLDRQWKHERQH
marrow circulation (and thus IO analyses) is unclear.
Some previous studies have concluded that IO blood samples can be 
used as a substitute for arterial or venous blood samples (7–9). However, this 
LQIRUPDWLRQLVEDVHGRQVWXGLHVZLWKYHU\GLɣHUHQWSRSXODWLRQVKHDOWK\YROXQWHHUV
haemodynamically stable haematologic patients or laboratory animals) than 
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emergency patients, who are the most likely target group of the POC analysis of 
IO samples. Unfortunately, the studies with unstable patients are scarce.
The statistical methods used in previous studies might mislead the readers. 
Correlation, linear regression and comparison of grouped means are the commonly 
used methods in previous studies. None of the methods indicate agreement, which 
is the relevant measure to determine whether the IO and arterial or venous values 
FDQEHXVHGLQWHUFKDQJHDEO\)DOVHLQWHUSUHWDWLRQRI,2YDOXHVFDQOHDGWRWKH
misdiagnosis and mistreatment of a critically ill patient. To avoid such situations, 
limitations of the previous studies and the method of POC analysis of IO samples 
KDYHWREHLGHQWL¿HG
The purpose of this dissertation is to provide understanding of how POC analyses 
of IO samples can be used to facilitate the assessment and treatment of emergency 
patients. This study reports on the existing literature of IO sample analyses and 
the feasibility and reliability of IO POC analyses within healthy volunteers and 
prehospital emergency patients. It also demonstrates how IO values act in relation 
to arterial and venous values during experimental CPR.
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2 LITERATURE REVIEW
2.1 POINT-OF-CARE TESTING 
2.1.1 DESCRIPTION OF POINT-OF-CARE TESTING
Point-of-care testing (POCT), also known as near-patient testing or bedside testing, 
is intended to provide test results more rapidly than those achieved in institutional 
laboratory settings. The key objective of POCT is to quickly provide a result so that 
proper treatment can be implemented faster, thus aiming for improved treatment 
outcome (3). Although POCT is particularly important in critical care areas, such 
as prehospital emergency medical services (EMS), it can also be useful in skilled 
nursing facilities and home health care delivery. POCT can be used in ED to optimise 
WKHWXUQRYHUWLPHVRIWKHSDWLHQWÀRZ,WFDQDOVRSURYLGHGLDJQRVWLFVHUYLFHVWR
remote health care units, which otherwise lack complete laboratory services. POCT 
should facilitate the treatment decisions of clinicians and / or provide convenience 
for the patient.
Results obtained from POCT should be comparable with those from the 
institutional laboratory. Because unreliable test results can potentially cause serious 
consequences, it is vital that the obtained results from POCT are trustworthy. POCT is 
often performed by the personnel who are not trained in medical laboratory practice. 
3UHDQDO\WLFDQDO\WLFDQGSRVWDQDO\WLFIDFWRUVFDQLQÀXHQFHWKHUHVXOWVRZLQJWR
many patient-related or provider-related reasons. The analytical performance of 
POCT in terms of imprecision and bias, compared with that of standard laboratory 
analyses, is a key measure of POCT reliability (4,12). Implementation, training, 
quality control and surveillance of the POCT should be an integral part of the 
management system of the health care unit (4). Few studies suggest good agreement 
between POCT and an institutional laboratory testing among emergency patients 
(13-15). However, their results cannot be generalised for all patient groups and all 
devices.
6HYHUDORXWFRPHPHDVXUHVFDQEHXVHGIRUHVWLPDWLQJWKHEHQH¿WVRI32&7
One main clinical outcome could be the proportion of patients for whom POCT 
changed the management or shortened the time to the initiation of treatment (11,17). 
Patient, physician, paramedic or nurse satisfaction, length of ED and hospital stay, 
mortality or economic outcomes should also be considered (18,19).
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2.1.2 POINT-OF-CARE TESTING IN PREHOSPITAL CRITICAL CARE
Decision-making in prehospital critical care is based on patient and event history, 
FXUUHQWFOLQLFDO¿QGLQJVDQGH[LVWLQJUHVRXUFHV7KHLQIRUPDWLRQLVRIWHQOLPLWHG
and additional support for decision-making can be obtained using POCT (18,19). 
Glucose measurement, coagulation tests, cardiac enzymes, blood-gas analyses and 
electrolyte and haemoglobin (Hb) measurements could provide useful information 
to EMS providers. Although the majority of the research concerning POCT within 
emergency patients addresses ED patients, a few interesting studies from the 
SUHKRVSLWDOVHWWLQJFDQEHPHQWLRQHG
Prehospital lactate measurements have been shown to predict in-hospital 
mortality and the need of in-hospital resuscitative care. In a prospective, multi-
centre study, prehospital lactate levels were measured in 387 trauma patients 
ZKRVHSUHKRVSLWDOV\VWROLFEORRGSUHVVXUHZDVEHWZHHQDQGPP+J(OHYDWHG
prehospital lactate level (t 2.5 mmol/l) was associated with the need for resuscitative 
FDUHGXULQJWKHIROORZLQJVL[KRXUVRUGHDWK5HVXVFLWDWLYHFDUHZDVGH¿QHGDVEORRG
transfusions (tXQLWVRUDQLQWHUYHQWLRQIRUKDHPRUUKDJHVXUJHU\SHOYLF¿[DWLRQ
or embolisation). Lactate was superior to blood pressure (BP) or shock index (heart 
UDWHV\VWROLFEORRGSUHVVXUHLQSUHGLFWLQJWKHQHHGIRUUHVXVFLWDWLYHFDUH
In another prospective study with 673 prehospital patients, elevated prehospital 
lactate levels (t 2 mmol/l) were strongly associated with in-hospital mortality, after 
adjustment for known covariates (21). The conclusions were complementary in a 
third study that evaluated the prognostic value of prehospital lactate within 124 
SDWLHQWVZLWKDEQRUPDOYLWDOVLJQV>V\VWROLF%3PP+JRUUHVSLUDWRU\UDWH
RU!SHUPLQRU*ODVJRZFRPDVFRUH*&6@7ZRSUHKRVSLWDOODFWDWH
PHDVXUHPHQWVZHUHSHUIRUPHGLQWKLVVWXG\WKH¿UVWRQDUULYDODWWKHVFHQHDQG
WKHVHFRQGMXVWEHIRUHDUULYDODW WKHKRVSLWDO0RUWDOLW\ZDVVLJQL¿FDQWO\KLJKHU
in patients with lactate levels t 3.5 mmol/l than in those with lactate levels < 3.5 
PPROOPHDVXUHGDWERWKWLPHSRLQWV WKHGHOWD ODFWDWH OHYHOZDVDVLJQL¿FDQW
independent predictor of in-hospital mortality (22).
A prospective, randomised, controlled trial for evaluating the value of prehospital 
arterial blood-gas (ABG) measurements in the accuracy of diagnostics and quality 
RIWUHDWPHQWZDVFRQGXFWHG LQ'HQPDUNGXULQJ±,QWKHVWXG\
222 patients were randomised to have either standard treatment or additional 
SUHKRVSLWDO$%*PHDVXUHPHQWVDYDLODEOH,QPDMRULW\RIWKHFDVHVZLWK
ABG measurements, the prehospital physician reported that ABG analysis results 
increased their perceived diagnostic precision. In the non-ABG group, the lack of 
ABG analysis results was perceived to have decreased the diagnostic accuracy in 
PDMRULW\RIWKHFDVHV$%*DQDO\VHVLQFUHDVHGWKHSUREDELOLW\RIWDUJHWLQJ
VSHFL¿FSUHKRVSLWDOWKHUDSHXWLFLQWHUYHQWLRQV+RZHYHUGLɣHUHQFHLQWKHRXWFRPH
was not observed.
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&RDJXODWLRQ LQ  SUHKRVSLWDO HPHUJHQF\ SDWLHQWVZDVPHDVXUHG XVLQJ D
POC device in a prospective observational study design (24). The assessment of 
international normalised ratio (INR) with a POC coagulometer was found feasible, 
and the prehospital POC INR values were in good agreement with the results of 
conventional in-hospital assessment. The emergency physicians in the hospital 
FRQVLGHUHGWKHSUHKRVSLWDOPHDVXUHPHQWVWREHRIKLJKRUPHGLXPYDOXH
among all the patients, and the value was considerably higher (63%) among 
neurological patients.
7KHGLDJQRVWLFYDOXHRISUHKRVSLWDO32&+EPHDVXUHPHQWVWRSUHGLFWVLJQL¿FDQW
KDHPRUUKDJHZDVVWXGLHGLQD)UHQFKPXOWLFHQWUHVWXG\ZLWKSDWLHQWV
3UHKRVSLWDO32&+EPHDVXUHPHQWFRXOGSUHGLFW VLJQL¿FDQWKDHPRUUKDJH7KH
GLɣHUHQFHEHWZHHQSUHKRVSLWDODQGLQLWLDOKRVSLWDO+EYDOXHVZDVSUHGLFWLYHIRU
PDMRUKDHPRUUKDJHDPRQJWUDXPDSDWLHQWV±ZLWKVDPHYROXPHRIÀXLGVLQIXVHG
ODUJHUGHFUHDVHLQ+EYDOXHVLQGLFDWHGVLJQL¿FDQWKDHPRUUKDJH
Future implications of prehospital POCT could be in streamlining the diagnostics 
and treatment of acute myocardial infarction (AMI) or stroke. Prehospital collection 
of blood biomarkers for increasing the speed and accuracy of diagnostics of ischemic 
VWURNHZDVIRXQGWREHIHDVLEOHDQGWLPHVDYLQJLQDVWXG\ZLWKLQWKURPERO\VLV
FDQGLGDWHV,QDSUHKRVSLWDOVWXG\IURP%HUOLQSODVPDJOLDO¿EULOODU\DFLGLF
protein (GFAP) measurements were performed in a mobile emergency stroke 
XQLWWRFRQ¿UPZKHWKHUGHWHUPLQLQJ*)$3FDQVXSSRUWLQGLɣHUHQWLDOGLDJQRVLV
between acute ischemic stroke and intracerebral haemorrhage (ICH) (27). GFAP 
OHYHOVDERYHWKHFXWRɣOHYHOQJPOZHUHDEOHWRFRQ¿UPWKHGLDJQRVLVRI
ICH, but the sensitivity of the marker was low, particularly in smaller haemorrhages. 
In the editorial of Biomarkers in Medicine, Lindsberg et al. discuss the potentials 
RISUHKRVSLWDO32&7 LQGLɣHUHQWLDOGLDJQRVWLFVDQGGHFUHDVLQJ WKHSUHKRVSLWDO
delays within stroke patients (28). If patients with brain haemorrhage could 
EH GLɣHUHQWLDWHG ZLWK SUHKRVSLWDO ELRPDUNHUV WKH\ FRXOG EHQH¿W IURP UDSLG
normalisation of coagulation and transfer to a hospital with neurosurgical facilities.
A protocol of an interesting Danish, multi-centre, randomised clinical trial with 
SDWLHQWVZDVUHFHQWO\SXEOLVKHGLQTrials (29). The study aims to discover 
whether adding prehospital copeptin measurements to the diagnostic path of 
suspected AMI patient would optimise the diagnostics and length of stay in the 
ED. The results have not been published yet.
2.1.3 POINT-OF-CARE TESTING DURING CARDIOPULMONARY RESUSCITATION
The advanced life support (ALS) guidelines instruct to actively search for and correct 
the reversible causes of CA during CPR (Figure 1) (5). According to the European 
5HVXVFLWDWLRQ&RXQFLO (5&*XLGHOLQHV IRU5HVXVFLWDWLRQHOHFWURO\WHDQG
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metabolic disorders can be screened with laboratory tests during CPR (6). In 
SUDFWLFHWKH¿UVW32&DQDO\VLVZRXOGPRVWOLNHO\RFFXUDIWHUWKHLQLWLDWLRQRI$/6
when opening a vascular access.
2.1.3 Point-of-care testing during cardiopulmonary resuscitation 
Figure 1
Figure 1.
ThrombosisTension
Pneumothorax
Tamponade
HypovolaemiaHyperkalaemia
HypothermiaHypoxia
Toxins
T
Figure 1. The 4 H’s and 4 T’s mnemonic to remember the reversible causes of cardiac arrest. (Copyright 
European Resuscitation Council – www.erc.edu – 2019_NGL_012)
7KHUHVXVFLWDWLRQJXLGHOLQHVVWDWHWKDWEORRGJDVHVDUHGLɤFXOWWRLQWHUSUHWGXULQJ
CA. The ABG may be misleading during CA; instead, central venous samples might 
provide better estimation of tissue pH. These arguments are based on studies by 
*UXQGOHUDQG:HLOHWDO LQ7KH¿UVWZDVDQH[SHULPHQWDOSRUFLQH
resuscitation study with sequential blood sample analyses from the artery and central 
vein. The researchers concluded that ABG fail as indicators of systemic acid–base 
VWDWXVDQGWLVVXHDFLGRVLV,QWKHVHFRQGVWXG\:HLOHWDO LQYHVWLJDWHGWKH
acid–base balance of arterial and mixed venous blood during CPR of 16 critically 
ill coronary care unit (CCU) patients. They noted that arterial pH, partial pressure 
of carbon dioxide (pCO2) and standard bicarbonate (HCO3GLGQRWVLJQL¿FDQWO\
FKDQJHGXULQJ&$FRPSDUHGZLWKWKHYDOXHVWDNHQEHIRUH&$+RZHYHUVLJQL¿FDQW
changes in pH and pCO2 were demonstrated in mixed venous blood. Weil et al. 
concluded that ABG may fail as appropriate guides for acid–base management 
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GXULQJ&35+RZHYHUWKHSDWLHQWSRSXODWLRQZDVYHU\GLɣHUHQWIURPWKHRXW
of-hospital cardiac arrest (OHCA) patients nowadays. All the study patients had 
major haemodynamic derangements before CA and none of the patients survived.
7XFNHUHWDOVKRZHGVLPLODU¿QGLQJVLQLQWKHLUH[SHULPHQWDOVWXG\RQ
pigs undergoing CA and CPR. They reported that untreated CA may be accompanied 
by normal arterial and mixed venous blood-gas levels. Tissue acidosis was only 
revealed after tissue perfusion was restored, and it was better shown in mixed 
YHQRXVEORRGVDPSOHV$FLGRVLVLVDFRPPRQ¿QGLQJGXULQJ&$DQG&35
KRZHYHUWKHXVHRIEXɣHUVLVFXUUHQWO\UHFRPPHQGHGRQO\LQFDVHVRIVHYHUHWULF\FOLF
antidepressant intoxications or CA associated with hyperkalaemia (5).
The resuscitation guidelines propose screening electrolyte abnormalities 
as reversible causes of CA (6). Hyperkalaemia as a possible cause of CA can be 
screened with POCT during CPR. During CA and CPR, the reduction in oxygen 
transport results in anaerobic metabolism, leading to metabolic lactic acidosis. This 
in turn shifts potassium from the intracellular space to the extracellular space. 
Therefore, the estimation of pre-arrest potassium levels, based on the intra-arrest 
POC measurements, is challenging and might result in false positive results. Besides, 
according to the resuscitation guidelines, little or no evidence supports the treatment 
of electrolyte abnormalities during CA (6).
The use of POC analyses during CPR for prognostication is an interesting subject 
that still needs further research. In a prospective observation study, Spindelboeck 
et al. measured ABG during CPR among 115 OHCA patients. They reported a 
trend towards higher partial pressure of arterial oxygen (paO2) values in patients 
who reached sustained return of spontaneous circulation (ROSC). Moreover, they 
found out that the arterio-alveolar carbon dioxide (CO2GLɣHUHQFH$D'&22) was 
associated with sustained ROSC, with the survivors having lower AaDCO2 values 
(33).
2.2 INTRAOSSEOUS ACCESS
2.2.1 ANATOMY AND PHYSIOLOGY OF BONE MARROW
Highly vascularised and innervated bone marrow is located within the cavities of 
bones (Figure 27KHVWURPDOFHOOVUHWLFXODUFHOOV¿EUREODVWVHQGRWKHOLDOFHOOV
and adipocytes) and the parenchymal cells (haematopoietic cells) are the two 
major cellular elements of bone marrow and represent its two primary functions: 
reticuloendothelial function and haemopoiesis. Several mechanisms regulate 
haemopoiesis: nervous system, humoral growth and inhibitory factors, and cell–
cell interaction between marrow cells (34-36).
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Figure 2. Structure of a long bone. The surface is compact bone, which is thicker in the diaphysis and 
thinner in the epiphyseal regions. Cancellous bone filled with red marrow is inside the epiphysis. The 
diaphysis is filled with yellow bone marrow which mainly comprises of adipocytes. (Figure reproduced 
with the permission of Anuj Kumar) (37)
In infancy, all the bone marrow is haemopoietic. During childhood, progressive fatty 
replacement of marrow occurs throughout the long bones. In adult life, only the 
bone marrow of the vertebrae, ribs, sternum, skull, sacrum, pelvis and the proximal 
ends of the femur, tibia and humerus is haemopoietic (Figure 3) (35,36). Their 
marrow becomes less productive by age. The adipose bone marrow is capable of 
reversion to haemopoiesis on demand. In experimental animal studies, marrow 
EORRGÀRZKDVEHHQVKRZQWRVLJQL¿FDQWO\LQFUHDVHDVDUHVXOWRIQRUPRYRODHPLF
and hypovolaemic anaemia (38,39). Medullary venous channels and nutrient 
and emissary veins connect the bone marrow to the vascular system. The bone 
marrow cavity does not collapse owing to the compact bone and the presence of 
bone trabeculae (Figure 4). This provides a non-collapsible, highly vascularised 
VSDFHIRUÀXLGDQGPHGLFDWLRQDGPLQLVWUDWLRQYLDHPHUJHQF\,2DFFHVVHYHQLQ
profound shock (2).
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2.2.2 Use of intraosseous access in emergency care 
CORTEX
RED MARROW
YELLOW MARROW 
CANCELLOUS BONE
Figure 3. The structure of a proximal end of a long bone. The cortex is thin, enabling IO needle penetration. 
The stability of the bone is achieved with the trabecular structure of the cancellous bone. The spaces 
between the bone trabeculae are filled with red bone marrow, which is gradually replaced by yellow 
marrow with aging. (Figure source: Wikimedia common)
Figure 3.
 
Figure 4.
2.2.2 Use of intraosseous access in emergency care 
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Figure 4. Histologic picture of bone marrow biopsy. Haematoxylin-eosin stain. (Figure by Johannes Dunkel)
2.2.2 USE OF INTRAOSSEOUS ACCESS IN EMERGENCY CARE
,2DFFHVVFDQEHFRQVLGHUHGD OLIHVDYLQJEULGJHWRGH¿QLWLYHYDVFXODUDFFHVV,W
LVUHFRPPHQGHGZKHQYDVFXODUDFFHVVLVLPSRVVLEOHGLɤFXOWRUOLNHO\WROHDGWR
GHOD\HGWUHDWPHQW LQHPHUJHQF\VLWXDWLRQV,QJHQHUDOFDQGLGDWHVIRU,2
access are burn patients, children, IV drug abusers and patients in shock or in cold 
environment. IO access can be used as a primary or rescue vascular access after 
failed venous access attempts (41). The local protocol in the EMS system should 
determine the indications and threshold for IO insertion (1,42,43).
&XUUHQWO\ WKUHHGLɣHUHQWPHWKRGVIRU LQWURGXFLQJ,2QHHGOHVDUHDYDLODEOH
manual, impact-driven and powered drill (1). Manual needles are hollow steel 
needles with removable trocars that prevent the bone fragments plugging the needle 
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during insertion. They are manually screwed into the target bone with twisting 
motion. Impact-driven needles require pressure which releases a spring-loaded 
mechanism for the penetration of the needle into the sternum or other target bone. 
The newer powered drill insertion technique (EZ-IO® automated intraosseous 
infusion system) is likely to provide faster insertion and better success rate than 
the previously used manual and spring-loaded devices (1,44-46).
The insertion site is selected based on the patient’s anatomy, patient’s age, 
how one can access the patient, presenting condition and the experience of the 
practitioner. Recommended locations for IO access for adults are the proximal 
ends of humerus and tibia or the distal end of tibia; for children, the recommended 
locations are the proximal or distal ends of tibia or the distal end of femur (41,47). 
IO access can also be inserted into the sternum, but devices specially designed for 
this purpose are required.
Bone marrow is highly vascularised; therefore, IO access is currently used for 
ÀXLGDQGPHGLFDWLRQDGPLQLVWUDWLRQ:LWKLQKHDOWK\YROXQWHHUVDQGH[SHULPHQWDO
DQLPDOVWXGLHVWKHDEVRUSWLRQUDWHVRIÀXLGVDQGPHGLFDWLRQVKDYHEHHQVKRZQWR
be comparable to those achieved by IV administration (48-52). Few case reports 
and experimental studies support blood product transfusion (53-56). Bjerkvig et 
al. have studied fresh whole-blood transfusion through the sternal IO route among 
voluntary military personnel (57). The study suggests the method to be safe and 
UHOLDEOHDQGWRSURYLGHVXɤFLHQWÀRZUDWHV
2.2.3 INTRAOSSEOUS ACCESS AND CARDIOPULMONARY RESUSCITATION
The resuscitation guidelines recommend using an IO access as an optional vascular 
DFFHVVGXULQJ&35IRUERWKDGXOWVDQGFKLOGUHQ8QWLOUHFHQWO\WKHUHVHDUFK
on using IO access in resuscitation has focused on the success rates and procedural 
times of IO insertion. In a prospective, randomised trial with 182 non-traumatic 
2+&$SDWLHQWVWKH¿UVWDWWHPSWVXFFHVVUDWHRIWLELDO,2DFFHVVZDVKLJKHUWKDQ
that of humeral IO or peripheral venous routes (91% vs. 51% and 43%, respectively) 
/HLGHOHWDOUHSRUWHGWKDWWKH¿UVWDWWHPSWVXFFHVVUDWHZDVKLJKHUDQGWKH
procedure time was faster with IO access than that with central venous (CV) access 
GXULQJPHGLFDODQGWUDXPDUHVXVFLWDWLRQ LQDQ(',2PLQ&9
8 min) (45).
The recent studies focus on CPR outcomes. Questioning whether resuscitation 
GUXJ DGPLQLVWUDWLRQ URXWHV ,2 YV ,9 DɣHFW RXWFRPH LV UHOHYDQW $ VPDOO
experimental study with 21 piglets showed that the adrenaline administration route 
KXPHUDO,2YV,9GLGQRWDɣHFW526&$QRWKHUH[SHULPHQWDOVWXG\ZLWK
VZLQHFRPSDUHGWKHHɣHFWVRIHDUO\DGPLQLVWUDWLRQRIDGUHQDOLQHYLD,2DFFHVV
(1 min after the start of the CPR) with the delayed administration of adrenaline via 
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,9URXWHPLQDIWHUWKHVWDUWRI&35LQSURORQJHGYHQWULFXODU¿EULOODWLRQ9)
Early IO adrenaline administration improved 24h-survival compared with delayed 
,9DGUHQDOLQYV(DUO\,2DGUHQDOLQHDGPLQLVWUDWLRQVHHPHGWRUHVXOW
PRUHRIWHQYVLQVXUYLYDOZLWKJRRGQHXURORJLFDORXWFRPHEXWWKH
GLɣHUHQFHZDVQRWVWDWLVWLFDOO\VLJQL¿FDQW
The results of four larger register-based studies are not consistent with their 
RXWFRPHV&OHPHQF\HWDOUHWURVSHFWLYHO\UHYLHZHG2+&$SDWLHQWVRXWRI
ZKRPKDGDQ,2DFFHVVDVDSULPDU\YDVFXODUURXWH%DVHGRQWKHHQGSRLQW
526&DWWLPHRI('DUULYDODQ,2¿UVWDSSURDFKZDVQRWLQIHULRUWRDQ,9DFFHVV
,QDPXOWLYDULDWHDGMXVWHGDQDO\VLVRIDUHWURVSHFWLYHUHJLVWHURI2+&$
patients, Feinstein et al. found that although access type was not associated with 
survival to discharge, IO access was associated with lower likelihood of ROSC and 
survival to hospitalisation (61). Two recent large register-based retrospective studies 
report opposing conclusions. In a study of 13,155 OHCA patients, out of whom 5% 
had an IO access as a primary vascular route, IO access was associated with poorer 
neurologic outcomes than IV access (62). In an analysis of 19,731 OHCA patients, 
out of whom 15.5% had primarily attempted IO access, there was (after adjustment) 
QRGLɣHUHQFHLQKRVSLWDOVXUYLYDORUVXUYLYDOZLWKIDYRXUDEOHQHXURORJLFIXQFWLRQ
however, IO access was associated with lower rates of sustained ROSC (63). It has to 
be emphasised that in observational studies, the causality regarding the association 
between vascular access and outcome is unclear.
2.2.4 CONTRAINDICATIONS AND COMPLICATIONS 
Contraindications for IO access insertion include fracture in the target bone, 
excessive tissue or absence of adequate anatomical landmarks, infection on the 
DUHDRISODQQHGLQVHUWLRQVLWHSUHYLRXVVLJQL¿FDQWRUWKRSDHGLFSURFHGXUHDWVLWHRU
previous IO access to the target bone within the past 48 h (41,47,64).
Complications associated with IO access are rare: less than 1% (2,42). Reported 
LQFLGHQFH RI RVWHRP\HOLWLV LV ± DQG LW LV JHQHUDOO\ DVVRFLDWHG ZLWK
bacteraemia, peripheral vascular disease, local skin infection or prolonged infusion 
(45,65,66). Another possible complication is extravasation, which if undetected, 
might lead to compartment syndrome (67). Other rare complications are local 
infections, penetration through the posterior cortex of the bone (68), catheter 
EHQGLQJDQGGLɤFXOW\LQUHPRYLQJWKH,2GHYLFHZKLFKFDQDOOEHSUHYHQWHGXVLQJ
a proper insertion technique and by frequent monitoring of the infusion site. To 
avoid complications, the insertion of IO access must be performed under sterile 
conditions and the length of usage should be limited to a maximum of 24 h (47).
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2.3 LABORATORY ANALYSES OF INTRAOSSEOUS SAMPLES
2.3.1 FEASIBILITY OF THE ANALYSES
Many previous study protocols have not reported on the success rates of the analyses 
,QVWXGLHVZKHUHLQGLɤFXOWLHVZHUHGHVFULEHGWKHPDMRUSUREOHPVHHPHG
to be clotting of the samples (72,73). In the experimental studies with sequential 
samples over time, the aspirates were easily obtained in the beginning; however, 
WKHDVSLUDWLRQEHFDPHPRUHGLɤFXOWRYHUWLPH+DHPRO\VLVZDVUHSRUWHG
in two studies with the IO samples of cats and dogs (77,78). Haemolysis could 
be one probable explanation for the elevated potassium values in the IO samples 
(Figure 5).
Figure 5.
(IV, left)
(IO, right)  
 
2.3.2 Comparison of intraosseous samples with conventional blood samples 
Figure 5. Micro-haematocrit capillary tubes 
for the analyses of intravenous haematocrit 
(left) and intraosseous myelocrit (right) from 
a study of dogs undergoing elective surgery. 
 
Intravenous sample (IV,  left): plasma (a), 
buffy coat (b), and red blood cells (c). 
 
Intraosseous sample (IO, right): fat (A), 
bone marrow particles (B), plasma (C), buffy 
coat (D), and red blood cells (E). (Figure 
reproduced with the permission of Søren 
Boysen and the publisher) (78)
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2.3.2 COMPARISON OF INTRAOSSEOUS SAMPLES WITH  
CONVENTIONAL BLOOD SAMPLES
%HFDXVHERQHPDUURZLVDPHWDEROLFDOO\DFWLYHWLVVXHWKDWLVGLɣHUHQWIURPFLUFXODWLQJ
blood, and located somehow between arterial and venous circulation, several 
SK\VLRORJLFDOGLɣHUHQFHVFDQEHH[SHFWHGZKHQFRPSDULQJ,2VDPSOHVZLWKDUWHULDO
and venous samples.
7KH¿UVWH[SHULPHQWDOVWXG\FRPSDULQJ,2VDPSOHVZLWKDUWHULDODQGYHQRXV
VDPSOHVLQGRJVZDVSXEOLVKHGLQ7KHVDPSOHVZHUHDQDO\VHGXVLQJ
an institutional laboratory analyser for a large variety of parameters. To the same 
article was integrated a blood culture study of 24 human patients with suspected 
sepsis. The 15 patients with positive blood cultures for bacteria or fungus had the 
same microbes present in the IO samples. The reliability of the IO analyses cannot 
EHLQWHUSUHWHGIURPWKHVWXG\RZLQJWRLQVXɤFLHQWVWDWLVWLFDOPHWKRGVZKLFKKDV
been the challenge in many of the following studies.
Several experimental studies have used haemodynamically unstable animal 
models. Kissoon et al. compared the acid–base status between venous and IO 
samples of nine piglets during CPR, concluding that during longer periods of CPR, 
,2EORRGPD\UHÀHFW ORFDODFLGRVLVDQG\LHOG ORZHUS&22 and higher pH values 
than the central venous blood (71). Studies with models of endotoxemic shock, 
hypothermia, hypovolaemia and hypoxia have concluded that IO samples were 
VLPLODU WRYHQRXVVDPSOHV7KHFRQFOXVLRQVKDYHEHHQGUDZQE\
comparing the mean values of IO measurements to the mean values of venous 
measurements; however, this method does not measure the intra-individual 
agreement. A recent study using proper statistical methods was performed within 
dogs in the Faculty of Veterinary Medicine of the University of Calgary (78). In 
WKHVWXG\GRJVRIGLɣHUHQWEUHHGVXQGHUZHQWHOHFWLYHNQHHRSHUDWLRQV,9DQG
IO samples were compared for various parameters [blood urea nitrogen, glucose, 
packed cell volume, total plasma protein, lactate, sodium (Na), potassium (K), 
chloride (Cl), urea, glucose, pH, anion gap, haematocrit (Hct), pO2 and pCO2@7KH
conclusion was that the IO aspirates, excluding K and Hct measurements, appear 
to be a reliable alternative.
0RQWH]HW DO DQG0LOOHU DW DOSHUIRUPHGVWXGLHVZLWKLQ DQG KHDOWK\
volunteers, respectively (9,84). Both studies used correlation and comparison of 
grouped means as statistical methods. Funding from an IO device manufacturer 
ZDVUHSRUWHGIRUERWK7KHVWXGLHVFRQFOXGHGWKDWWKHUHZDVDVLJQL¿FDQWFRUUHODWLRQ
between IO and venous samples for lactate (Montez) and glucose, urea, creatinine, 
Cl, total protein, albumin, red blood cell count, Hb and Hct but not for platelet 
count, white cell count, Na, K, CO2 and ionised calcium (iCa) (Miller). The used 
statistical methods do not report the agreement between IO and venous samples.
In four studies, the agreement between IO and venous samples within 
haematologic or oncologic haemodynamically stable patients, either adults or 
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children, had been assessed (7,8,85,86). Veldhoen et al. compared the venous 
DQG,2VDPSOHVRIFKLOGUHQSUHVHQWHGIRUVFKHGXOHGGLDJQRVWLFERQHPDUURZ
aspiration (86). An i-STAT® POC analyser was used for analyses. The statistical 
methods used in the study for assessing the agreement followed the recommended 
guidelines. The agreement was found to be clinically acceptable for pH, base excess 
%(1DL&DDQGJOXFRVH&OLQLFDOO\UHOHYDQWGLɣHUHQFHVZHUHIRXQGIRUS&22, pO2, 
HCO3 and K. The other studies with haemodynamically stable patients have used 
Pearson’s correlation or comparison of grouped means as statistical methods, and 
WKHUHVXOWVFRQFHUQLQJDJUHHPHQWDUHFRQÀLFWLQJ+XUUHQHWDODQG*ULVKDPHWDO
reported that K values in IO samples were elevated (8,85).
The agreement between IO and IV samples within emergency patients has been 
analysed in only one previous study (69). Seventeen critically ill patients needing 
resuscitation and IO access at the ED of a hospital were included in the study. 
Of these, 16 patients arrived in the ED in CA, and the total in-hospital mortality 
in the study group was 76%. IO and IV samples were obtained within 5 min and 
analysed using an EPOC® POC analyser. The Bland–Altman method was used for 
comparison. Reasonable agreement for pH, HCO3, Na and BE, moderate agreement 
for lactate and poor agreement for K, pO2, pCO2, and glucose were reported in this 
study population.
2QO\ ¿YH VWXGLHV SXEOLVKHG XQWLO  KDYH IROORZHG WKH UHFRPPHQGHG
statistical methods for comparing IO samples with venous or arterial samples 
(Table 17KHVHVWXGLHVKDYHYHU\GLɣHUHQWSRSXODWLRQVFULWLFDOO\LOOHPHUJHQF\
patients (69), cardiovascular stable, anesthetised haematologic patients (86), 
pigs with sequentially changing cardiac outputs (82,87), and anesthetised dogs 
undergoing elective knee surgery (78).
Table 1. Details of the studies with recommended statistical methods.
Subjects n Circulation Comparison Analyser
Kissoon et al. (82) pigs 14 sequential changes in cardiac output mixed venous Laboratory
Veldhoen et al. (86) humans 20 cardiovascular stable, anaesthetised
peripheral 
venous POC (i-STAT®)
Tallman et al. (69) humans 17 cardiac arrest /critically ill peripheral venous POC (EPOC®)
Ackert et al. (78) dogs 12 general anaesthesia for elective surgery
jugular 
venous
POC (i-STAT®, 
and other) and 
laboratory
Strandberg et al. (87) pigs 12
pigs during stable 
circulation and after 
haemorrhage of 20% and 
40% of the blood volume
arterial, 
central 
venous
POC (i-STAT®, 
and other) and 
laboratory
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2.3.3 RELEVANT PARAMETERS
A large variety of parameters from IO samples have been studied (Table 2). 
Measurements of electrolytes, acid–base balance, blood gases and Hb could provide 
important information about an unstable patient for decision-making, and these 
could be parameters of interest within IO samples. Although measurements of opioid 
concentration, troponin, creatinine, amylase or liver enzymes from IO samples 
provide academically interesting information, they are not vital for fast decision 
making in critical care (72,75). These analyses could often be performed after venous 
access has been achieved.
Blood typing and screening from IO samples is interesting owing to the 
establishment of prehospital transfusion protocols. Before transfusing O-negative 
red blood cells, drawing a blood sample for blood type screening and cross-matching 
is important. Successful ABO- and Rh-blood typing from IO access has been reported 
in two studies with 28 and 71 patients admitted to haemato-oncological service for 
bone marrow examination (88,89).
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Table 2. Parameters for which the agreement of IO and arterial or venous samples has been studied.
pH H
CO
3
BE N
a
K pO
2
pC
O
2
G
lu
co
se
La
ct
at
e
iC
a
H
b
H
ct
A
LA
T
A
SA
T
G
G
T
A
FO
S
Cr
ea
Ur
ea
W
BC
RB
C
Tr
om
Cl A
lb
um
in
To
ta
l p
ro
te
in
CK LD Bl
oo
d 
ty
pi
ng
O
th
er
Bäckman*(88) x
Strandberg (87) x x x x x x x x x x x x x x x x
Ackert (78) x x x x x x x x x x x x x1
Tallman* (69) x x x x x x x x x
Eriksson (76) x x x x x x
Strandberg (72) x2
Eriksson (75) x3
Strandberg (74) x
Veldhoen* (86) x x x x x x x x x
Strandberg. (90) x x x x x x x x
Montez*(84) x
Larsson (91) x4
Strandberg (83) x x x x x x x x x x
Miller* (9) x x x x x x x x x x x x x x x
Greco (92) x x x x x x x x x x x x x x x5
Hurren * (85) x x x x x x x x x
Voelckel (70) x x x x
Johnson (80) x x x x x x x6
Abdelmoneim (73) x x
Kissoon (71) x x
Dhein (77) x x x x x x x x x x x x7
Ummenhofer* (7) x x x x x x x x x x x x x x x x x x x8
Kissoon (82) x x
Kissoon (81) x x x x
Jennings (93) x x x x x x x
Brickman* (89) x
Grisham* (8) x x x x x x x x x x x x9
Orlowski** (79) x x x x x x x x x x x10
Brickman (94) x x x
* human study
** combined animal and human study
1 anion gap, packed cell volume
2 thromboelastography, PT, APTT, 
fibrinogen
3 TnI
4 plasma level of morphine
5 MCH, MCHC, MCV
6 Mg
7 cholesterol, phosphate
8 bilirubin
9 SpO210 microbial culture studies, bilirubin, 
phosphorus
ABG arterial blood gases
AFOS alkaline phosphatase
ALAT alanine aminotransferase
APTT partial thromboplastin time
ASAT aspartate aminotransferase
BE base excess
CK creatine kinase
Cl chloride
Crea creatinine
GGT gamma-glutamyl transferase
Hb haemoglobin
HCO3
- standard bicarbonate
Hct haematocrit
iCa ionised calcium
INR international normalised ratio
K potassium
LD lactate dehydrogenase
MCH mean corpuscular haemoglobin
MCHC mean corpuscular haemoglobin 
concentration
MCV mean corpuscular volume
Mg magnesium
Na sodium
paO2 partial pressure of arterial 
oxygen
pCO2 partial pressure of carbon 
dioxide
pO2 partial pressure of oxygen
PT prothrombin time
RBC red blood cell count
SpO2 peripheral oxygen saturation
TnI troponin I
Trom thrombocyte count
WBC white blood cell count
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2.4 VALIDATION OF NEW MEASUREMENT TECHNIQUES
2.4.1 METHOD COMPARISON TECHNIQUES
Prior to implementing a new measurement technique into clinical practice, it 
needs proper validation. Clinical and Laboratory Standards Institute (CLSI), a 
global leader in the standardisation and harmonisation of laboratory standards, 
creates guidelines of specialty areas. The Standard document EP09 Measurement 
Procedure Comparison and Bias Estimation Using Patient Samples describes 
methods for comparison and determining the bias between two measurement 
procedures (95).
Method comparison is a common technique applied by device manufacturers 
and laboratories to estimate the bias of the results from the new method compared 
with those from a standard method. The assumption that the new measurement 
procedure provides ‘true’ values requires bias estimation. Bias means the systematic 
measurement error of the new method compared with the comparator (95).
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics recommends 
VWDWLVWLFDODSSURDFKHVWRREMHFWLYHO\DQDO\VHWKHGDWDIRUWKHGLɣHUHQFHVEHWZHHQ
the measurements (96). The recommended methods are (a) DoD plot (distribution 
RIGLɣHUHQFHV D IUHTXHQF\SORW RUKLVWRJUDPRI WKHGLVWULEXWLRQRIGLɣHUHQFHV
with measures of central tendency and dispersion); (b) Bland–Altman method 
DGLɣHUHQFHELDVSORWZKLFKVKRZVGLɣHUHQFHVDVDIXQFWLRQRIWKHDYHUDJHVRI
measurements); and (c) regression analysis.
2.4.2 BLAND–ALTMAN METHOD
The Bland–Altman method, which we used in our studies, is widely used for 
evaluating method comparison data. It is a simple and illustrative method to 
interpret. It was created by statisticians Martin Bland and Douglas Altman for 
comparing measurements in clinical medicine; however, it has also been widely 
DGRSWHGLQFOLQLFDOFKHPLVWU\7KH%ODQG±$OWPDQJUDSKLVDSORWRIGLɣHUHQFHV
against the average of the results by the two methods (Figure 6). It provides 
LQIRUPDWLRQRQWKHGLɣHUHQFHVDQGWKHLUGLVSHUVLRQZKLFKLVXVHIXOLQHYDOXDWLQJ
whether agreement problems exist over the entire range or only in certain ranges 
of measurements. The Bland–Altman graph demonstrates the bias and the limits 
RIDJUHHPHQW/2$7KHELDVLVWKHDYHUDJHRIWKHLQGLYLGXDOGLɣHUHQFHVRISDLUHG
measurements and represents the systematic error. LOA is the ± 1.96 standard 
GHYLDWLRQ6'LQWHUYDOZLWKLQZKLFKRIWKHGLɣHUHQFHVIDOODQGLWUHSUHVHQWV
the random error between the measurement methods (97). It is very important to 
HPSKDVLVHWKDWWKH%ODQG±$OWPDQPHWKRGRQO\GH¿QHVWKHFDOFXODWHGDJUHHPHQW
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intervals; the acceptable limits in practice should always be based on clinical 
estimation (98).
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Figure 6. An example of a Bland–Altman graph. The average of the paired measurements by two different 
methods is presented on the X-axis, and the difference of the paired measurements by two different 
methods is presented on the Y-axis. The centremost dotted line represents bias (average difference of 
all the paired measurements), and the outermost dot/dash lines represent the 95% limits of agreement 
(LOA) of the bias ( ± 1.96 standard deviation (SD)). K, IO, A and mmol/l represent potassium, intraosseous, 
arterial and millimoles per litre, respectively.
2.4.3 INSUFFICIENT STATISTICAL METHODS FOR METHOD COMPARISON
A commonly used measure of agreement is the Pearson product moment correlation 
FRHɤFLHQW(YHQKLJKFRUUHODWLRQGRHVQRWQHFHVVDULO\LQGLFDWHJRRGDJUHHPHQW
Correlation generally indicates dependence (mainly a linear relationship) between 
WKHYDULDEOHV$FRUUHODWLRQFRHɤFLHQWUHÀHFWVQHLWKHUWKHVORSHRIWKHFRUUHODWLRQ
line nor the intercept deviation from zero. Thus, even in situations with perfect 
correlation, the agreement can though be poor. Only a ‘line of identity’ (also called 
‘line of equality’ or ‘1:1 line’) in which the correlation line leaves at a 45° angle from 
the origin in x,y coordinates would represent perfect agreement (Figure 7) (99).
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Figure 7.
Figure 8
Figure 7. The Pearson product moment correlation coefficient (ʌ) can range between –1 (total negative 
correlation) and +1 (total positive correlation) (A). A value of 1 implies that a linear equation perfectly 
describes the relationship between X and Y, with all data points lying on a line for which Y increases as 
X increases. It does not reflect the slope of the relationship (B). (Figure source: Wikimedia commons)
Another inadequately used statistical method for method comparison studies is the 
comparison of grouped means (96). The average value of all individuals’ results 
obtained using the new method is compared with an average value of the same 
individuals’ results measured using the standard method. If the averages of the 
groups are similar, this has been erroneously interpreted to indicate good agreement 
and interchangeability between the methods. This method ignores the intra-
individual bias between the measurement methods and leads to false assumptions.
6WDWLVWLFDOVLJQL¿FDQFHWHVWLQJZLWKDpaired sample t-test should also not be used 
WRGHWHUPLQHWKHHTXLYDOHQF\RIPHDVXUHPHQWV3DLUHGt-test measures the 
average bias and does not indicate the equivalency of measurements throughout 
the analytical measurement range (Figure 8).
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Paired difference between measurements
Average (   ) = 0
Figure 8. An example of a paired sample t-test. Measurements with two different methods (blue and red 
points). An arrow indicates the difference between paired measurements. Compared with the standard 
method (red points), the new method (blue points) can give lower values in the lower measurement range 
and higher values in the upper range. The average of the differences can be zero (equalling large p-value), 
leading to a false interpretation of no difference between measurements.

3 STUDY QUESTIONS
This study aims to provide knowledge to support or contradict the use of POC 
DQDO\VHVRI,2VDPSOHVZLWKLQHPHUJHQF\SDWLHQWVDQGWR¿QGSURSHULQGLFDWLRQV
for using them to support decision-making in emergency care.
7KHIROORZLQJDUHWKHVSHFL¿FREMHFWLYHV
:KDWLVWKHVFLHQWL¿FHYLGHQFHFRQFHUQLQJWKHDQDO\VHVRI,2VDPSOHV" 
(I)
Are the analyses of IO samples feasible with an i-STAT®SRLQWRIFDUHDQDO\VHU"
(II, III, IV)
How do the POC values from IO samples agree with those from arterial and venous 
EORRGVDPSOHV"'RHVWKHDJUHHPHQWSHUVLVWLQFULWLFDOLOOQHVVDQGFDUGLDFDUUHVW"
(II, III, IV)
+RZ,2DUWHULDODQGYHQRXVVDPSOHVWDNHQGXULQJ&35UHÀHFWWKHSUHDUUHVWVWDWH"
(III)
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4 MATERIALS AND METHODS
4.1 STUDY DESIGN
The dissertation comprises four studies approaching the study question from 
GLɣHUHQWSHUVSHFWLYHVD V\VWHPDWLF UHYLHZRI WKH OLWHUDWXUHRQDQDO\VLQJEORRG
samples from IO access (Study I) and three observational prospective studies 
evaluating the feasibility and reliability of IO POC analyses in three distinct 
cohorts, including healthy volunteers (Study II), animals being resuscitated from 
VF (Study III) and prehospital critical care patients (Study IV) (Table 3).
Table 3. Characteristics of the observational studies of the dissertation.
n Material IO insertion site Comparator
Study II 31 healthy volunteers proximal tibia arterial and peripheral venous blood
Study III 23 anesthetised pigs proximal tibia arterial and central venous blood
Study IV 33 prehospital critical care patients proximal humerus arterial blood
4.2 METHODS OF THE SYSTEMATIC LITERATURE REVIEW
The review protocol was registered in the International prospective register of 
V\VWHPDWLFUHYLHZV35263(52GDWDEDVH&5'DQGWKHGDWDZHUH
collected and reported following the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines. We searched for articles 
comparing IO blood samples with venous or arterial blood samples for parameters 
relevant to emergency care. The search was performed from Medline and Embase 
databases, Cochrane Library and the clinicaltrials.gov registry. Data published until 
6HSWHPEHUZHUHLQFOXGHGZLWKRXWODQJXDJHUHVWULFWLRQV%HFDXVHRIWKHVPDOO
number of human POC studies, we included both animal and human studies and 
the studies using conventional laboratory analyses and POC devices. Data search 
was performed using terms covering both ‘Bone marrow’ and ‘Laboratory analysis’ 
¿HOGVTable 4).
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Table 4. Search terms used in the literature search of the systematic literature review (Study I).
Bone marrow Laboratory analysis
MeSH major topic bone and bones / analysis
bone and bones / chemistry
bone and bones / diagnosis
bone marrow / analysis
bone marrow / chemistry
bone marrow / diagnosis
bone marrow examination
intraosseous infusion
blood gas analysis
point-of-care systems
point-of-care testing
blood chemical analysis / methods
Search terms
Title/Abstract
intraosseous
bone marrow
point-of-care
laboratory analysis
blood gases
chemistry
The selection process was independently performed by two authors (Jousi and 
1XUPLE\¿UVWVFUHHQLQJWKHWLWOHVDQGDEVWUDFWVDQGLIQHHGHGWKHIXOOWH[WYHUVLRQV
of the articles. The selected articles were assessed for eligibility in relation to the 
LQFOXVLRQFULWHULD7KHUHIHUHQFHVRI WKHVHOHFWHGDUWLFOHVZHUH UHYLHZHG WR¿QG
additional relevant articles. From the selected articles, the data were sought for the 
following variables: the target population, sample size, equipment used in sampling 
and analyses, sample site, success rate of the analyses, blood discarded before sample 
ZLWKGUDZDODQDO\VHGSDUDPHWHUVVWDWLVWLFDOPHWKRGVIXQGLQJVRXUFHVDQG¿QGLQJV
For the quality assessment of the included studies, two authors (Jousi and 
Laukkanen-Nevala) individually assessed the studies and rated them on a self-
FUHDWHGVFDOH±IRFXVLQJRQWKHXVHRISURSHUVWDWLVWLFDOPHWKRGVLQWKHVWXGLHV
(Table 5). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (96) 
and CLSI EP09-A3 Measurement Procedure Comparison and Bias Estimation 
using Patient Samples (95) were used as references.
Table 5. The quality assessment of the studies in the systematic literature review.
3 The Bland–Altman method has been used and the limits of agreement have been reported
2 The Bland–Altman method (proper or modified) has been used but the information about 
variation is absent 
1 Statistical methods are insufficient for method comparison studies (such as correlation or 
comparison of grouped means)
0 Information for evaluating the statistical methods is insufficient
4.3 STUDY SETTINGS AND COHORTS 
OF THE OBSERVATIONAL STUDIES
,QWKH¿UVWREVHUYDWLRQDOVWXG\6WXG\,,ZHVWXGLHGWKHIHDVLELOLW\DQGUHOLDELOLW\
of IO POC analyses within healthy individuals. For the study, 31 voluntary, healthy 
paramedic students from Saimaa University of Applied Sciences were recruited. 
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We organised, based on the students’ own wish, a training session where paramedic 
students practiced IO needle insertion on each other under supervision. During 
the training session, we collected blood samples from IO access, radial artery 
and antecubital vein from each participant. We used sterile technique including 
facial masks, sterile gloves and surgical skin disinfection with alcohol to reduce 
the risk of infection for the volunteers. The volunteers were all healthy and over 
18 years of age. After risk assessment, we decided to perform IO needle insertion 
to the proximal tibia to minimise the risk of complications. Exclusion criteria were 
immunocompromising condition or medication, skin infection around the puncture 
site, pregnancy and breast feeding.
In the second observational study (Study III), we studied using an experimental 
animal model the relation of IO blood samples compared with arterial and venous 
VDPSOHVGXULQJGLɣHUHQWSKDVHVRI&$DQG&35%HFDXVHVWXG\LQJWKHVXEMHFWLQ
real-life situations is not possible, we participated in an experimental CA model 
GHVLJQHGIRUH[DPLQLQJWKHHɣHFWRIFRPSDUHGZLWKLQVSLUHGR[\JHQ
IUDFWLRQRQEUDLQR[\JHQDWLRQDQGSRVW&$PLWRFKRQGULDOIXQFWLRQ:HWRRN
EORRGVDPSOHVDWIRXUSUHGH¿QHGWLPHSRLQWVIURPWKH,2VSDFHWKHIHPRUDODUWHU\
and the central vein from 23 anesthetised pigs (Figure 9).
Preparation VF CPR Post ROSC
0 min 7 min 12 min5 min 10 min 
post ROSC
T0 T1 T2 T3
13 min
Advanced CPR
Individual duration
RO
SC
T0 Blood sample at baseline before induction of VF
T1 Blood sample 5 minutes after induction of VF
T2 Blood sample 5 minutes after initiation of CPR
T3 Blood sample 10 minutes after ROSC
VF        Ventricular fibrillation
CPR      Ventilation (FiO2 50% or 100%) and chest compressions (100/min) with LUCAS TM
Advanced CPR       Defibrillation every 2 min, adrenalin 1 mg every 2 min until ROSC or at least 20 min
ROSC    Return of spontaneous circulation 
Figure 9. Timeline of the experiment (Figure from Study III, reprinted with permission from Resuscitation).
For the protocol, CA (VF) was electrically induced in the pigs with a 4-V electrical 
current via a pacing wire inserted into the right ventricular wall. VF was left 
untreated for 7 minutes to simulate a real-life scenario. After 7 minutes, CPR was 
initiated with mechanical chest compressions (LUCAS®DWDIUHTXHQF\RISHU
PLQXWHDQGPDQXDOEDJYDOYHYHQWLODWLRQVDWDIUHTXHQF\RISHUPLQXWH$IWHU
®
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PLQXWHVRI&35GH¿EULOODWLRQZDVSHUIRUPHG,IVLQXVUK\WKPZDVQRWDFKLHYHG
UHVXVFLWDWLRQZDVFRQWLQXHGZLWKGH¿EULOODWLRQVLIVWLOOLQDVKRFNDEOHUK\WKPDQG
EROXVHVRIDGUHQDOLQHHYHU\PLQXWHVXQWLO526&RUIRUDWOHDVWPLQXWHVLH
27 minutes from CA. In the end, the pigs were euthanised with a lethal dose of 
SRWDVVLXPFKORULGHPPRO
In the third observational study (Study IV), we took IO and arterial samples 
IURPHPHUJHQF\SDWLHQWVWUHDWHGE\WKHSK\VLFLDQVWDɣHG+HOLFRSWHU(PHUJHQF\
Medical Services (HEMS) unit during routine missions. Two out of 35 patients 
were excluded owing to a reversal of consent. The included patients were critically 
ill adults (minimum age of 18 years) who needed prehospital POC laboratory 
diagnostics and an IO access for the treatment of acute illness or accident, based 
on the treating physician’s assessment. The IO access was never inserted only for 
taking blood samples. Patients in CA were excluded from this study protocol, but the 
inclusion after ROSC was possible. The blood samples were taken within maximum 
a 5-min (pO2 and pCO2RUPLQDOOWKHRWKHUYDOXHVWLPHJDSDQGVLJQL¿FDQW
physiological changes were not allowed to have happened between the two samples. 
1RPHGLFDWLRQVRUÀXLGVZHUHDOORZHGWREHLQIXVHGWRWKH,2DFFHVVEHIRUHWDNLQJ
the sample. The study protocol was registered beforehand in the Clinical Trials 
GDWDEDVH1&7
4.4 BLOOD AND INTRAOSSEOUS SAMPLES AND POINT-OF-
CARE ANALYSES
To obtain samples from the IO space, we inserted 15G 25-mm (to the proximal 
tibia, Studies II and III) or 45-mm (to the proximal humerus, Study IV) IO needles 
using the Arrow  EZ-IO® device. In the Study III, we inserted a new needle for 
HDFKUHSHDWHGVDPSOH:HGUHZWKH LQLWLDO±POEORRG6WXGLHV,,,DQG,9
from the IO space without discarding any waste blood. In Study II, we took two 
UHSHDWHG,2VDPSOHVWKH¿UVWZDVWKHLQLWLDOPODQGWKHVHFRQGZDVWDNHQDIWHU
the removal of 2-ml waste blood) to evaluate the need for discarding waste blood 
before actual sampling.
The control samples for Study II were taken from the radial artery and antecubital 
vein. For the Study III, the control samples were taken via catheters in the internal 
jugular vein and femoral artery. For the Study IV, the control samples were taken 
IURPWKHUDGLDOEUDFKLDORUIHPRUDODUWHU\RIWKHSDWLHQWWKURXJKD*DUWHULDO
cannula or via a single puncture.
)RUDOO VDPSOHVPOGU\KHSDULQ  ,8EORRGJDVV\ULQJHVZHUHXVHG ,I
GLɤFXOWLHVZLWKGUDZLQJDQ,2VDPSOHIURPWKH,2VSDFHXVLQJDGU\KHSDULQV\ULQJH
were encountered, a normal 2-ml syringe was used for aspiration, and the sample 
was immediately injected into a heparinised syringe.
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All samples were analysed using an i-STAT® Handheld or i-STAT Alinity (in 
WKH6WXG\,9IURPRQZDUGVRZLQJWRDFKDQJHLQWKHHTXLSPHQWRIWKH
HEMS unit) POC device with CG4+ and CG8+ cartridges (in the Study IV, only 
CG8+ cartridges were used) (Table 6). We analysed the following parameters that 
we consider to be the values of interest in critically ill patients and during CA: pO2, 
pCO2, BE, HCO3, pH, lactate, Na, K, iCa, glucose, Hb and Hct.
Table 6. Laboratory parameters in the CG4+ and CG8+ i-STAT® test cartridges used in the studies.  
pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen; TCO2, total carbon dioxide; 
HCO3, standard bicarbonate; BE, base excess; sO2, oxygen saturation; Na, sodium; K, potassium; iCa, 
ionised calcium; Hct, haematocrit; Hb, haemoglobin. *calculated 
CG4+ CG8+
lactate Na
pH K
pCO2 iCa
pO2 glucose
TCO2* Hct
HCO3* Hb*
BE* pH
sO2* pCO2
pO2
TCO2*
HCO3*
BE*
sO2*
4.5 QUESTIONNAIRE
)RU6WXG\,9ZHZDQWHGWRGH¿QHWKHPD[LPDODFFHSWDEOHELDVEHWZHHQ,2VDPSOHV
and arterial samples in clinical practice. We sent a questionnaire via e-mail to 16 
H[SHULHQFHGSUHKRVSLWDOHPHUJHQF\SK\VLFLDQVIURPGLɣHUHQWSDUWVRI)LQODQG:H
asked them the extent of the bias they would be ready to accept when treating a 
critically ill prehospital patient if they only had the POC IO analysis results available 
without having a possibility to obtain arterial or venous analyses. We compared 
their answers with the measured biases in our study population and then evaluated 
whether the measured biases in the study setting would be acceptable in clinical 
practice.
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4.6 STATISTICAL METHODS
In the Studies II and IV, we used the Bland–Altman method to calculate the bias and 
the 95% LOA between IO and blood sample values. The Bland–Altman method yields 
DQLQIRUPDWLYHJUDSKUHJDUGLQJWKHDJUHHPHQWZKHUHLQWKHLQGLYLGXDOGLɣHUHQFHV
EHWZHHQWKHUHVXOWVPHDVXUHGXVLQJWKHWZRGLɣHUHQWPHWKRGVDUHSORWWHGDJDLQVW
the mean values of the measurements to display the average bias and the LOA. In 
general, the bias represents systematic error, and the LOA represent the random 
HUURUGHVFULELQJWKHYDULDWLRQRIWKHGLɣHUHQFHVFigure 10).
Figure 10. A diagram explaining the principles of the Bland–Altman graph.
A Agreement interval (±1.96 standard deviation of the bias, should contain 95% of the future bias 
measurements)
B 95% confidence interval of LOA (±1.96 standard error of the limit of agreement, reports the 
precision of estimation)
C 95% confidence interval of bias (±1.96 standard error of the bias, reports the precision of 
estimation)
LOA Limit of agreement
To assess the reliability of the measurements in Study II, we calculated intraclass 
FRUUHODWLRQFRHɤFLHQWV,&&ZLWKFRQ¿GHQFHLQWHUYDOV&,EDVHGRQDVLQJOH
PHDVXUHPHQWFRQVLVWHQF\ZD\PL[HGHɣHFWVPRGHO,&&LVDUHOLDELOLW\ LQGH[
XVXDOO\XVHGLQWHVWUHWHVWLQWUDUDWHUDQGLQWHUUDWHUUHOLDELOLW\DQDO\VHV7KHUH
DUHIRUPVRI,&&VHDFKLQYROYLQJGLVWLQFWDVVXPSWLRQVLQWKHLUFDOFXODWLRQDQG
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OHDGLQJWRGLɣHUHQWLQWHUSUHWDWLRQV7KHUHSRUWLQJRI,&&VVKRXOGDOZD\VLQFOXGH
LQIRUPDWLRQDERXWWKHW\SHPRGHODQGGH¿QLWLRQ7KHUHOLDELOLW\FDQEHLQWHUSUHWHG
(based on the 95% CI of the ICC estimate) as follows (Table 7):
Table 7. Intraclass correlation coefficient (ICC) values and how they indicate the reliability of the analyses.
ICC
<0.5 poor
0.5–0.75 moderate
0.75–0.9 good
>0.9 excellent
,Q 6WXG\ ,,,ZHSORWWHG WKH ODERUDWRU\ SDUDPHWHUV DW GLɣHUHQW WLPHSRLQWV WR
demonstrate the development of the values during CA and CPR and presented 
the data in the plots as means with 95% CIs. We also calculated the individual 
GLɣHUHQFHVEHWZHHQUHVXVFLWDWLRQVDPSOHV,2DUWHU\DQGYHLQDQGWKHSUHDUUHVW
DUWHULDOVDPSOHVDQGUHSUHVHQWHGWKHGLɣHUHQFHVDVER[SORWVWRGHPRQVWUDWHWKH
change of laboratory values from the pre-arrest state.
In Study IV, we evaluated the factors related to the technical failures of the POC 
IO analyses by comparing the data from patients with failed analyses with that 
IURPWKHSDWLHQWVZLWKVXFFHVVIXODQDO\VHV:HFDOFXODWHGWKHVWDWLVWLFDOVLJQL¿FDQFH
RIWKHGLɣHUHQFHVRIWKHGHPRJUDSKLFIDFWRUVXVLQJWKH0DQQ:KLWQH\8WHVWIRU
FRQWLQXRXVYDULDEOHVDQGǒ2 -test for categorical variables. For proportions, we 
FDOFXODWHGWKH&,XVLQJWKHPRGL¿HG:DOGPHWKRG
$OOJUDSKVDUHSURGXFHGZLWK*UDSK3DG3ULVPYHUVLRQVD±6DPSOH
VL]HFDOFXODWLRQVZHUHDFRPSURPLVHEHWZHHQDFKLHYLQJFOLQLFDOO\VXɤFLHQW&,IRUWKH
ELDVDQGWKH/2$VDQGWKHGLɤFXOW\ZLWKVDPSOHFROOHFWLRQ%ODQGHWDOUHFRPPHQG
VDPSOHVL]HVXSWR±IRUPHWKRGFRPSDULVRQVWXGLHVKRZHYHUWKLVZRXOG
KDYHEHHQLPSRVVLEOHWRDFKLHYHLQRXUVWXG\VHWWLQJV. In general, sample size 
FDOFXODWLRQIRUWKH%ODQG±$OWPDQPHWKRGLVEDVHGRQWKH6'RIWKHGLɣHUHQFHVd) 
EHWZHHQWKHWZRPHDVXUHPHQWPHWKRGVDQGWKHGHVLUHG&,RIWKH/2$7KH
standard error (SE) of the 95% LOA is approximately
.
ඨ͵ݏଶ݊  
Table 8
Table 8.
Sample size 95% CI 
where s LVWKH6'RIWKHGLɣHUHQFHVd) and n LVWKHVDPSOHVL]H7KHFRQ¿GHQFH
interval is d ± 1.96 s ± 1.96 SE. When the desired accuracy of the LOA is determined, 
the sample size can be calculated using this formula (Table 8).
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Table 8. Examples of the effect of different sample sizes on the confidence interval of the bias and the 
limits of agreement. (CI, confidence interval; SD, standard deviation)
Sample size 95% CI
10 ± 1.1 SD
12 ± 1 SD
30 ±0.6 SD
50 ±0.5 SD
100 ± 0.3 SD
200 ±0.2 SD
300 ±0.1 SD
The sample size in Study II was estimated based on the sample sizes in the previous 
publications because the SD of the biases between the IO and arterial/venous 
samples was unknown. The sample size in Study IV was calculated a priori based 
on the SD of the measured biases between the IO and arterial measurements in 
Study II because information about the SD of the biases from critically ill patients 
was not available. By including 35 patients in the study, we were prepared for the 
SRVVLEOHPLVVLQJGDWDIURP¿YHSDWLHQWV:LWKDVDPSOHVL]HRISDWLHQWV WKH
FRQ¿GHQFHPDUJLQDOVRIWKH/2$IRUWKHODERUDWRU\SDUDPHWHUVZHUHFRQVLGHUHG
VXɤFLHQWTable 9).
Table 9. Confidence marginal (±) of the 95% LOA calculated with the sample size of 30 patients based 
on the SD of the values in Study II. (Na, sodium; K, potassium; iCa, ionised calcium; BE, base excess; 
HCO3, standard bicarbonate; pO2, partial pressure of oxygen; pCO2, partial pressure of carbon dioxide; Hb 
haemoglobin; Hct, haematocrit)
Parameter Confidence marginal
Na (mmol/l) 1.76
K (mmol/l) 0.63
iCa (mmol/l) 0.043
BE (mmol/l) 0.72
HCO3 (mmol/l) 0.9
pO2 (kPa) 1.23
pCO2 (kPa) 0.37
Hb (g/l) 25.3
Hct (g/l) 7.45
Glucose (mmol/l) 0.26
Lactate (mmol/l) 0.20
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4.7 ETHICAL ASPECTS
All the research projects were investigator-initiated and conducted according to the 
principles of the Declaration of Helsinki.
The study protocol for Study II was approved by the Coordinating Ethics 
&RPPLWWHHRI+HOVLQNL8QLYHUVLW\+RVSLWDODQGWKH
+HOVLQNL8QLYHUVLW\+RVSLWDO%RDUG$ZULWWHQLQIRUPHG
consent was obtained from all the participants and a follow-up was organised in 
case of complications.
The study protocol for Study III was approved by the Finnish National Animal 
([SHULPHQW %RDUG (6$9, DQG WKH +HOVLQNL 8QLYHUVLW\
+RVSLWDO%RDUG+867KHVWXG\DGKHUHGWRWKHAnimal 
Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.
The study protocol for Study IV was approved by the Ethics Committee of the 
+HOVLQNL8QLYHUVLW\+RVSLWDO +86  DQG WKH+HOVLQNL
8QLYHUVLW\+RVSLWDO%RDUG+86'HOD\HGLQIRUPHGFRQVHQW
of the patients or the next of kin was obtained before including the laboratory results 
in the analyses, as approved by the Ethics Committee.

5 RESULTS
5.1 PARTICIPANTS
The two observational studies and the experimental study contain 87 participants 
in total, 23 of them being animals (Table 10 and Figure 11).
Table 10. Characteristics of the study participants. Continuous variables presented as medians (IQR).
* at T0 before induction of VF. (IQR, interquartile range; GCS, Glasgow coma score; BP, blood pressure; 
SpO2, peripheral oxygen saturation; Hb, haemoglobin)
Study II Study III Study IV
n 31 23 33
Characteristics healthy voluntary paramedic students healthy landrace pigs
critically ill prehospital 
patients
Age 24 (22–27) young 58 (39–70)
Weight, range (kg) 26–38
Gender (male) 42% both 61% 
GCS 3 (3–4)
Systolic BP (mmHg) 121 (96–142)
Heart rate (min–1) 89 (70–114)
SpO2 (%) 97 (95–100)
pH art 7.39 (7.41–7.43) 7.56 (7.50–7.61)* 7.30 (7.22–7.38)
Hb art (g/l) 145 (134–159) 88 (82–92)* 136 (126–146)
Traumatic brain injury 24%
post CPR 24%
Intoxication 21%
Cardiac 12%
Severe trauma 9%
Other 9%
 
Figure 11. The medical conditions of the patients included in Study IV. (CPR, cardiopulmonary resuscitation)
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5.2 SYSTEMATIC LITERATURE REVIEW
The systematic search of the articles comparing the agreement of IO samples with 
arterial or venous samples yielded 27 articles to be included in the qualitative 
synthesis (Figure 12).
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
AddiƟonal reĐords idenƟĮed 
from the referenĐes 
(n = 11) 
ReĐords idenƟĮed 
through database 
searĐhing  
(n = 839) 
ReĐords exĐluded based 
on Ɵtle, abstraĐt or full-
text 
(n = 823) 
Full-text arƟĐles assessed 
for eligibility 
(n = 16) 
Studies inĐluded in 
qualitaƟve synthesis 
(n = 27) 
 
Original arƟĐles (n=24) 
AbstraĐts (n=3) 
Figure 12. The study selection.
The included studies were heterogenic by populations, the haemodynamic state of 
the participants, sample sizes and statistical methods (Table 11).
Table 11. Characteristics of the 27 studies included in the systematic literature review. 
* n > 27 because in some studies, several statistical methods were used. (POC, point-of-care; IO, intraosseous)
Study population humans n = 8
animals n = 18
both n = 1
Haemodynamic state unstable animals n = 9
unstable humans n = 1
stable animals n = 9
stable humans n = 8
Sample size mean 15
median 12
range 5–34
Comparator venous blood n = 18
arterial blood n = 2
both n = 7
Analyser POC n = 5
laboratory n = 22
Waste blood reported having discarded 1.5–2 ml n = 12
Conflicting interests with an IO device 
manufacturer
reported n = 6
Statistical methods used for comparison * correlation n = 6
comparison of group means n = 14
bias without variation n = 9
bias with variation n = 3
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RESULTS
Three studies included in the systematic review followed the recommended statistical 
guidelines for method comparison studies, which include the calculation of bias and 
WKHUHSRUWLQJRIWKHYDULDWLRQRIWKHGLɣHUHQFHV7KHSRSXODWLRQVLQWKH
three studies were heterogeneous, comprising haemodynamically unstable animals 
(n = 14), critically ill emergency patients (n = 17) and haemodynamically stable, 
anaesthetised paediatric haematologic patients (n  ,QWZRRIWKHVHVWXGLHV
POC analysers were used for analyses.
5.3 FEASIBILITY OF THE ANALYSES 
$QDO\VHVRIWKH,2VDPSOHVZHUHWHFKQLFDOO\VXFFHVVIXOLQ&,±RIWKH
healthy voluntary paramedic student population (Study II). We observed a trend 
WRZDUGVORZHURYHUDOOVXFFHVVUDWH&,±LQWKHFULWLFDOO\LOOSUHKRVSLWDO
patient study population (Study IV), p 7KHSDWLHQWVZKRVH,2VDPSOHDQDO\VHV
were technically unsuccessful were older and had higher GCS than the ones whose 
analyses were successful (Table 12).
Table 12. Characteristics of the patients with technically unsuccessful and successful IO sample analyses 
in Study IV.
Data are presented as medians (IQR) or proportions. p values are calculated with ʖ2 test for categorical 
variables and the Mann-Whitney U-test for continuous variables. (GCS, Glasgow coma score; BP, blood 
pressure; SpO2, peripheral oxygen saturation; Hb, haemoglobin; art, arterial)
Technically unsuccessful IO  
sample analysis (n = 7)
Successful IO sample analysis  
(n = 23) p value
Male 4 (57%) 17 (74%) 0.3966
Age (years) 74 (66–83) 47 (30–63) 0.0008
GCS 13 (3–15) 3 (3–3) 0.0056
Systolic BP (mmHg) 105 (89–147) 125 (103–142) 0.4855
Pulse rate (min–1) 84 (51–120) 86 (70–115) 0.4715
SpO2 (%) 95 (88–96) 98 (95–100) 0.0985
pH art 7.31 (7.25–7.40) 7.30 (7.21–7.37) 0.5011
Hb art (g/l) 133 (126–161) 138 (130–145) 0.9453
The necessity to draw waste blood before obtaining the actual IO sample was studied 
in Study II by comparing the initial blood sample with the second sample taken after 
discarding 2 ml of waste blood. The agreement between the initial IO sample and 
the second sample was tested using the Bland–Altman method. The biases were 
FOLQLFDOO\LQVLJQL¿FDQWH[FHSWIRU+E+FWDQGSRWDVVLXP,QFDVHRISRWDVVLXPWKH
initial IO sample had better agreement with arterial and venous samples than the 
second one (Table 13).
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Table 13. Bias (95% CI) between the results of the initial and second IO samples (after 2 ml of waste 
blood was discarded) calculated using the Bland–Altman method. (CI, confidence interval; Na, sodium; 
K, potassium; iCa, ionised calcium; BE, base excess; HCO3, standard bicarbonate; pO2, partial pressure of 
oxygen; pCO2, partial pressure of carbon dioxide; Hb, haemoglobin; Hct, haematocrit)
Bias (95% CI)
Na (mmol/l) –0.14 (–1.17; 0.88)
K (mmol/l) –0.77 (–1.17; –0.38)
iCa (mmol/l) 0.02 (–0.01; 0.05)
pH –0.02 (–0.03; –0.01)
BE (mmol/l) –0.32 (–0.69; 0.04)
HCO3 (mmol/l) 0.2 (–0.15; 0.55)
pO2 (kPa) –0.26 (–1.06; 0.54)
pCO2 (kPa) 0.25 (0.11; 0.39)
Hb (g/l) 11.52 (–3.69; 26.72)
Hct (%) 3.41 (–1.07; 7.89)
Glucose (mmol/l) 0.07 (0; 0.13)
Lactate (mmol/l) –0.05 (–0.12; 0.01)
5.4 AGREEMENT OF INTRAOSSEOUS SAMPLES WITH 
ARTERIAL AND VENOUS SAMPLES
:HGH¿QHGWKHDJUHHPHQWRI,2YDOXHVZLWKDUWHULDODQGYHQRXVYDOXHVXVLQJWKH
Bland–Altman statistical method in three studies (Studies II–IV). The following 
¿JXUHV SUHVHQW WKH V\QWKHVLV RI WKH DJUHHPHQW GDWD IURP VHYHUDO VRXUFHV WKH
observational studies (Studies II and IV), experimental study (Study III), three 
methodologically correct studies from the systematic literature review (Study I) 
and two recent methodologically correct studies that have been published after the 
data collection period of the systematic review (Figure 13).
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Figure 13. Combined data about the agreement between IO samples and arterial or venous samples from 
the following studies: the observational studies of the dissertation (Study II–IV), methodologically correct 
studies from the systematic literature review (Study I) (Tallman et al., Veldhoen et al., Kissoon et al.) and 
the methodologically correct studies published after the data collection period of the systematic literature 
review. (Ackert et al., Strandberg et al.) (69,78,82,86,87)
Each row displays the bias and the 95% LOA of the measured parameter. The squares represent human 
studies and the dots represent animal studies. The blue colour indicates agreement of the IO samples with 
venous samples and the red colour indicates the agreement with arterial samples. 
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For the Study III, the following timepoints of blood samples are represented:
T0 before CA
T1 five minutes after the initiation of VF
T2 five minutes after the initiation of CPR
T3 ten minutes after ROSC
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Figure 14.
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Figure 14. The dynamic change of the POC values from IO, arterial and venous samples. Data are presented 
as means (95% CI). T0 = baseline, before cardiac arrest, T1 = after five minutes of untreated VF, T2 = five 
minutes after the initiation of cardiopulmonary resuscitation, T3 = ten minutes after return of spontaneous 
circulation. (Figure from Study III, reprinted with permission from Resuscitation) 
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RESULTS
The clinical relevance of the bias, based on our questionnaire to 16 prehospital critical 
FDUHSK\VLFLDQV LVKLJKO\GHSHQGHQWRQWKHFOLQLFDOFRQWH[WVSHFL¿FSDWLHQWDQG
laboratory parameters in question. Determining an acceptable standard bias level 
ZLWKRXWFOLQLFDOFRQWH[WZDVFRQVLGHUHGWREHGLɤFXOW,QDQVZHUWRDJHQHUDOLVHG
question about an acceptable bias level between IO and arterial POC measurement 
in the treatment of a critically ill patient when only the IO POC results are available, 
the following bias values were received (Table 14).
Table 14. Prehospital critical care physicians’ (n = 16) opinions on the largest acceptable bias between 
IO and arterial/venous values. Data presented as medians (IQR). (IQR, interquartile range; Na, sodium; 
K, potassium; iCa, ionised calcium; BE, base excess; HCO3, standard bicarbonate; pO2, partial pressure of 
oxygen; pCO2, partial pressure of carbon dioxide; Hb, haemoglobin; Hct, haematocrit)
Maximum accepted bias
Na (mmol/l) 5 (4.3, 7.5)
K (mmol/l) 0.5 (0.2, 0.6)
iCa (mmol/l) 0.1 (0.05, 0.16)
pH 0.05 (0.02, 0.08)
BE (mmol/l) 2.0 (1.0, 3.0)
HCO3 (mmol/l) 3.0 (2.0, 5.0)
pO2 (kPa) 1 (0.6, 1.5)
pCO2 (kPa) 0.5 (0.3, 1.0)
Hb (g/l) 10 (10, 14)
Hct (%) 5 (3, 5)
Glucose (mmol/l) 0.6 (0.5, 1.0)
5.5 POINT-OF-CARE ANALYSIS OF INTRAOSSEOUS SAMPLES 
DURING CARDIAC ARREST AND RESUSCITATION
In Study III, we demonstrated the dynamic change of the common laboratory values 
GXULQJUHVXVFLWDWLRQDQGWKDW,2DUWHULDODQGYHQRXVYDOXHVFKDQJHGLɣHUHQWO\IURP
another (Figure 14).
We studied how the samples taken during CPR represent the pre-arrest state 
DQGZKHWKHUWKHUHDUHGLɣHUHQFHVLQWKHVDPSOHVREWDLQHGIURPGLɣHUHQWVDPSOLQJ
VLWHV7KHGLɣHUHQFHVEHWZHHQDUWHULDO,2DQGYHQRXV&35VDPSOHVFRPSDUHGZLWK
the ‘golden standard’ arterial pre-arrest sample are displayed in Table 15.
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Table 15. Differences between the values of the samples drawn during cardiopulmonary resuscitation (T2) 
compared with the arterial value before cardiac arrest (T0). Parameters are presented as medians (IQR).
ART = Arterial value during cardiopulmonary resuscitation (T2) minus arterial value before cardiac arrest (T0).
IO = IO value during cardiopulmonary resuscitation (T2) minus arterial value before cardiac arrest (T0).
VEIN = Venous value during cardiopulmonary resuscitation (T2) minus arterial value before cardiac arrest 
(T0).
(BE, base excess; HCO3, standard bicarbonate; K, potassium; Na, sodium; pCO2, partial pressure of carbon 
dioxide; pO2, partial pressure of oxygen; iCa, ionised calcium; Hb, haemoglobin)
ART IO VEIN
Lactate (mmol/l) 8.6 (10.0 – 7.5) 9.3 (11.3 – 8.1) 7.7 (9.3 – 6.0)
pH –0.38 (–0.33 – –0.46) –0.41 (–0.35 – –0.46) –0.45 (–0.38 – –0.53)
BE (mmol/l) –15 (–14 – –18) –9 (–7 – –11) –14 (–12 – –17)
HCO3 (mmol/l) –9.8 (–8.3 – –12.8) –0.8 (0.4 – –3.2) –6.7 (–3.8 – –7.8)
K (mmol/l) 3.3 (4.0 – 2.7) 4.4 (4.9 – 3.9) 2.8 (3.7 – 1.9)
Na (mmol/l) –5 (–4 – –5) –3 (–2 – –6) –3 (–2 – –4)
pCO2 (kPa) 2.9 (4.6 – 1.9) 6.5 (9.2 – 5.9) 6.2 (7.4 – 4.4)
pO2 (kPa) 1.1 (10.6 – –1.6) –8.6 (–7.5 – –10.3) –7.3 (–6.3 – –8.8)
Glucose (mmol/l) 11.7 (13.0 – 8.9) –3.8 (–2.6 – –5.4) 8.2 (10.6 – 4.5)
iCa (mmol/l) 0.05 (0.07 – 0.02) 0.0 (0.1 – –0.1) 0.1 (0.1 – 0.0)
Hb (g/l) 24 (27 – 17) 17 (24 – 10) 21 (24 – 0)
7KHPDLQ¿QGLQJVRISRLQWRIFDUHDQDO\VHVGXULQJ&35
• Acidaemia was detectable in IO and venous samples during untreated VF 
but in arterial samples only after the initiation of CPR.
• The potassium values from the IO, arterial and venous samples were higher 
during CPR than the pre-arrest values [mean elevations of 4.4 mmol/l 
6'PPROO6'DQGPPROO6'UHVSHFWLYHO\@
• The elevated glucose values were detected in arterial and venous samples 
during CPR but not in IO samples.
• The pO2 and pCO2 values from IO samples closely followed those from the 
venous samples.

6 DISCUSSION
6.1 RATIONAL BASIS OF THE STUDIES
Several previous studies suggest good correlation between IO and venous/arterial 
samples (7-9,82,84). Accordingly, one of the leading IO device manufacturers 
UHSRUWVVWDWLVWLFDOO\VLJQL¿FDQWFRUUHODWLRQVEHWZHHQ,2DQGYHQRXVVDPSOHV IRU
several parameters, including Hb and Hct measurements (47). However, a review 
RIWKHSUHYLRXVVWXGLHVSUHVHQWVFRQÀLFWLQJUHVXOWVIRUGLɣHUHQWSDUDPHWHUV7KLV
PLJKWEHDUHVXOWRIYDULRXVSDUWO\LQVXɤFLHQWVWDWLVWLFDOPHWKRGVXVHGLQWKHVWXGLHV
Method comparison is common in laboratory medicine, where equipment 
and method development require regular comparison between the new and the 
existing, golden standard method. A fundamental publication in Lancet, by Bland 
and Altman in 1986 provides important statistical guidelines for assessing the 
DJUHHPHQWEHWZHHQWZRPHWKRGVRIFOLQLFDOPHDVXUHPHQW0RVWRIWKHHDUOLHU
studies evaluating the analyses of IO samples have not followed the recommended 
statistical methods; the conclusions are based on determining the correlation or 
comparison of grouped means.
,QJHQHUDOLWLVYHU\XQOLNHO\WKDWWZRGLɣHUHQWPHWKRGVZRXOGH[DFWO\DJUHHDQG
SURYLGHLGHQWLFDOUHVXOWVIRUDOOLQGLYLGXDOV32&WHVWLQJFDUULHVDQHUURUPDUJLQDO
by the method itself as well as the comparison of arterial with venous blood-gas 
PHDVXUHPHQWV,PSRUWDQWPHDVXUHVDUHWKHDPRXQWDQGGLUHFWLRQWKDW
WKHQHZPHWKRGGLɣHUVIURPWKHROGRQHDQGZKHWKHUWKHPHDVXUHPHQWELDV LV
V\VWHPDWLFDOO\KLJKHUORZHURUYDULHVZLWKLQWKHPHDVXUHPHQWUDQJH%\GH¿QLQJ
the bias level and type, adjustments can be made for using the new method.
All published studies comparing IO samples with arterial or venous samples, 
including our own studies, fail to provide an unequivocal answer for whether IO 
samples can be used for laboratory analyses. They can suggest a direction, depending 
on the parameter and situation, but they cannot provide an explicit solution, mainly 
RZLQJWRWKHLQVXɤFLHQWVDPSOHVL]HVDQGWKXVSRZHURIWKHVWXGLHV7KHFRUUHFW
ZD\WRSODQDPHWKRGFRPSDULVRQVWXG\LVWR¿UVWSUHVSHFLI\WKHODUJHVWFOLQLFDOO\
acceptable bias between the measurements: for example, by a Delphi-method with 
FOLQLFDOH[SHUWV7KLV LVGLɤFXOWEHFDXVHDOOYDULDEOHVDQGYDULRXVFOLQLFDO
VFHQDULRVQHHGWREHFRQVLGHUHG7KHVHFRQGVWHSLVWRGH¿QHWKHQXOOK\SRWKHVLV
for example, a hypothesis that the two methods agree. In practice, this means that 
WKHPD[LPXPDOORZHGGLɣHUHQFHEHWZHHQWKHPHDVXUHPHQWPHWKRGV') would fall 
outside the 95% CI of the LOA (Figure 15). The sample size can then be calculated 
based on the expected bias, SD of the individual biases and maximum allowed 
GLɣHUHQFH'), considering the desired alpha and beta error levels. A problem here 
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is the lack of previous information about the SD of the individual biases from the 
study population.
Figure 15. Defining the sample size for the Bland–Altman method. The maximum allowed difference should 
fall outside the 95% CI of the LOA. (LOA, limit of agreement; CI, confidence interval).
In practice, achieving studies with required sample sizes, especially within critically 
ill patients, is demanding; therefore, the possibility of proving the null hypothesis is 
WKHRUHWLFDOO\DOPRVWLPSRVVLEOH5HMHFWLQJWKHQXOOK\SRWKHVLVRZLQJWRLQVXɤFLHQW
sample sizes and concluding that IO samples cannot be used for POC analyses would 
mean abandoning a potentially useful method because of inadequate statistical 
power. However, the subject needs more research, and especially using the Bland–
Altman method instead of correlation. A collection of studies with small sample 
VL]HVPLJKWWKRXJKEHPRUHEHQH¿FLDOWKDQQRVWXGLHVRUODUJHVWXGLHVZLWKLQFRUUHFW
methods.
2XU¿UVWREVHUYDWLRQDOVWXG\6WXG\,,ZDVSULPDULO\SODQQHGWRDVVHVVWKH
feasibility of the IO POC analyses within healthy volunteers. Two earlier studies using 
healthy voluntary subjects for IO sample analyses have been published; however, 
the comparison of the values was performed using correlation or comparison 
of grouped means (9,84). The problem with using laboratory values of healthy 
voluntary subjects is that the values are usually within the reference range and 
the information about agreement outside of the normal levels remains unknown.
In practice, POC analysis of IO samples would most likely be applied within 
the critically ill patients for whom IV access cannot be achieved and POC analyses 
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are needed. Our prehospital study is the second one to assess IO sample analyses 
within critically ill patients, apart from a study in the hospital ED (69). In the 
hospital study, the patients were more severely ill: non-traumatic CA patients and 
other critically ill patients requiring immediate resuscitation, resulting in 47% 
mortality in the ED and 76% during hospitalisation. So far, no other studies have 
EHHQFRQGXFWHGZLWKXQVWDEOHKXPDQSDWLHQWV,PSRUWDQWLQVLJKWVLQWRWKHHɣHFWV
of unstable haemodynamics in the POC analyses of IO samples can be gathered 
IURPWKHXQVWDEOHDQLPDOPRGHOV+RZHYHUWKHLUUHVXOWVPLJKW
not be applicable to the population of critically ill patients.
6.2 FEASIBILITY OF THE ANALYSES
,QRXU¿UVWREVHUYDWLRQDOVWXG\6WXG\,,WKHVXFFHVVUDWHZDVKLJKLQWKHDQDO\VHV
RI\RXQJKHDOWK\YROXQWHHUV&,±6XUSULVLQJO\WKHVXFFHVVUDWHZDV
ORZHU&,±LQWKHDQDO\VHVRIFULWLFDOO\LOOSUHKRVSLWDOSDWLHQWV6WXG\
IV). Tallman et al. reported in their study with critically ill hospital patients that 
WKH\GLGQRWKDYHVLJQL¿FDQWWHFKQLFDOGLɤFXOW\LQREWDLQLQJPDUURZVDPSOHVDQG
analysing them using the EPOC POC analyser (69). They did not report the success 
rates, and one of the inclusion criteria was that a marrow sample could be obtained. 
6RPHSDWLHQWVPLJKWQRWKDYHEHHQLQFOXGHGRZLQJWRWKHGLɤFXOW\LQREWDLQLQJ
an IO sample. The median age of the included patients in their study was 67 years 
(range of 12–93 years). The median (range) ages of our patient samples in the 
6WXGLHV,,DQG,9ZHUH±DQG±\HDUVUHVSHFWLYHO\
Reporting of the success rates varies within the other previous studies. Eriksson 
et al. reported in their studies with porcine models with repeated samples that IO 
DVSLUDWHVZHUHHDVLO\REWDLQHGGXULQJWKH¿UVWKRXUVRIWKHH[SHULPHQWDOWKRXJK
DVSLUDWLRQEHFDPHPRUHGLɤFXOWRYHUWLPH0RQWH]HWDOUHSRUWHGLQWKHLU
study of IO sample analysis using i-STAT® in a population of healthy volunteers 
DVXFFHVVUDWHRIVXEMHFWVWKHUHVWEHLQJH[FOXGHGRZLQJWRFORWWLQJRIWKH
samples (84). In the study with patients subjected for diagnostic bone marrow 
examinations, Hurren reported having excluded 2/15 samples because of problems 
caused by fat and clotting (85). Abdelmoneim et al. reported that 4% of the samples 
within an unstable animal model could not be analysed owing to the clotting of 
EORRGLQWKHDQDO\VHURUGLɤFXOWLHVLQZLWKGUDZLQJWKHVDPSOHV7KHDQDO\VHV
in the studies by Hurren and Abdelmoneim et al. were performed with conventional 
laboratory equipment.
:H¿UVWVSHFXODWHGWKDWK\SHUFRDJXODELOLW\GXULQJDFXWHLOOQHVVHQYLURQPHQWDO
factors such as temperature or challenges in the sample analyses during the 
concomitant treatment of a critically ill patient could have contributed to the lower 
success rate. In our own studies, the IO samples from the prehospital patients were 
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taken from the proximal humerus, whereas the samples from the healthy volunteers 
ZHUHWDNHQIURPWKHSUR[LPDOWLELD:HGRQRWDVVXPHWKHVDPSOLQJVLWHWRDɣHFW
the success rate. The post-hoc analysis revealed that the patients with failed analyses 
were older than the ones with successful analyses. This could be explained by the 
gradual adiposity of the bone marrow with age. In clinical practice, this could indicate 
that the method of POC analysis of IO samples might not be applicable within elderly 
SDWLHQWV$QRWKHUVWDWLVWLFDOO\VLJQL¿FDQWGLɣHUHQFHEHWZHHQWKHSDWLHQWJURXSVRI
failed and successful analyses was the level of consciousness. The reason and clinical 
UHOHYDQFHRIWKLV¿QGLQJUHPDLQXQNQRZQ
6.3 AGREEMENT ANALYSES
Before new methods are adopted in clinical practice, their agreement with the 
HVWDEOLVKHG µJROGHQVWDQGDUG¶PHWKRGKDVWREHYHUL¿HG7KHJHQHUDODPRXQWRI
bias, its direction and distribution throughout the measurement range should 
EHH[DPLQHG&RQVLGHULQJZKHWKHUWKHELDVZRXOGPDNHDFOLQLFDOGLɣHUHQFH LV
important. Several previous studies assessing the usability of IO samples have made 
WKHLUFRQFOXVLRQVEDVHGRQLQVXɤFLHQWVWDWLVWLFDOPHWKRGVDQGVPDOOVDPSOHVL]HV
Often correlation has been interpreted as agreement.
We found that the reliability of potassium analyses from IO samples was 
LQVXɤFLHQWRZLQJWRDV\VWHPDWLFELDVEHWZHHQ,2DQGDUWHULDODQGYHQRXVVDPSOHV
Higher potassium values in the IO samples have been reported in several previous 
VWXGLHVDVZHOOZKLFKLVFRQVLVWHQWZLWKRXU¿QGLQJV7ZR
previous studies have reported opposing results, but these studies did not use the 
Bland–Altman method for agreement analyses (7,79). One potential reason for 
hyperkalaemia in IO sample analyses could be haemolysis owing to the higher 
negative pressure needed for aspirations (Figure 16).
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K 105 mmol/l
Na 11 mmol/l
K 4 mmol/l
Na 140 mmol/l
After haemolysis the sample 
would include 3% of contents 
from broken red blood cells 
Normal blood sample Haemolysed blood sample
K 7 mmol/l  (+76%)
Na 136 mmol/l (-3%)
K 105 mmol/l
Na 11 mmol/l
Figure 16. Schematic calculation of the effect of haemolysis on plasma sodium and potassium levels.
If the haemolysed sample would include 3% of contents from broken red blood cells , the plasma potassium 
level would increase as much as 76% (plasma [K] after haemolysis =  97% × 4 mmol/l + 3% × 105 mmol/l 
= 7 mmol/l) while the plasma sodium level would decrease by only 3% (plasma [Na] after haemolysis = 
97% × 140 mmol/l + 3% × 11 mmol/l = 136 mmol/l) (96,107). 
2XU¿QGLQJRIXQUHOLDELOLW\ZLWKLQWKH+EDQG+FWPHDVXUHPHQWVKDVEHHQFRQ¿UPHG
only in one other study (78). On the contrary, several studies report that the Hb and 
Hct measurements from IO samples are highly predictive or reliable (7-9,85,92). 
Again, all these studies used other methods than the Bland–Altman. All three studies 
using proper statistical methods, included in our systematic literature review, did 
not analyse Hb or Hct values (69,82,86). In our studies, the general biases (the 
average of all paired measurement biases) for Hb and Hct were close to zero. If 
this bias value is interpreted without taking the LOA into account, the conclusions 
are false. For example, in our own studies, the bias in a single Hb measurement 
FRXOGEHXSWRJOEHWZHHQ,2VDPSOHVDQGDUWHULDOYHQRXVVDPSOHV,IDOOWKH
Hb measurements from IO samples would be pooled and compared with the pooled 
results of arterial Hb measurements, the averages might be equal even if the paired 
PHDVXUHPHQWVIRURQHLQGLYLGXDOPLJKWKDYHDVLJQL¿FDQWGLɣHUHQFH,QWKHFDVHRI
Hb and Hct measurements, the wide LOA makes the agreement poor in general 
DQGFRQWUDGLFWVDQDO\VLQJWKHPIURP,2VDPSOHV7KLV¿QGLQJZDVFRQVWDQWLQDOO
our observational studies and may be attributable to the pre-analytical problems 
within POC analyses, such as coagulation of the sample before analysis. More likely 
H[SODQDWLRQVDUHWKHKDHPDWRSRLHWLFIXQFWLRQRIWKHERQHPDUURZDQGWKHGLɣHUHQW
cell compositions of peripheral blood and bone marrow.
55
6.4 POINT-OF-CARE TESTING DURING CARDIAC ARREST
Screening the reversible causes of CA is an important part of resuscitation protocols. 
A limited number of methods are available to achieve this in the prehospital setting. 
Investigating the medical history of the patient and the events and complaints 
preceding the CA is most important. POC ultrasound examination and POC 
laboratory analyses can be used to supplement the collected information. The 
knowledge of what the laboratory values during CA indicate or could be used to 
screen for is surprisingly limited. Moreover, the treatment options for electrolyte and 
acid–base balance abnormalities or the impact of their correction on the outcome 
ODFNHYLGHQFH
In general, the metabolites and electrolytes between the tissues and blood 
are in equilibrium, and blood sample analyses provide useful information about 
WKHWLVVXHVDQGPHWDEROLVP7KH ORZÀRZVWDWHGXULQJ&35GLɣHUV IURPVWDEOH
circulation, and the assumptions from a stable circulation do not apply during CPR. 
The circulation and blood pressure during standard CPR markedly varies between 
LQGLYLGXDOV7KHHɣHFWRIPHFKDQLFDOFKHVWFRPSUHVVLRQGHYLFHVVKRXOGDOVR
be taken into account. It can be assumed that during CPR, the blood samples do 
QRWUHÀHFWWKHWLVVXHVLQWKHVDPHZD\DVGXULQJVWDEOHFLUFXODWLRQ0RUHRYHUWKH
VDPSOHVWDNHQIURPGLɣHUHQWDQDWRPLFDOVLWHVPD\GLɣHURZLQJWRWKHUHGLVWULEXWLRQ
of the circulation. Central venous samples have been suggested to provide better 
estimation of acid–base balance than arterial samples (5,31). In practice, central 
venous blood samples are generally unavailable in resuscitations.
The difficulties in interpreting electrolyte abnormalities during CA are 
demonstrated in our experimental resuscitation study (Study III). When 
hyperkalaemia was detected in arterial, venous or IO samples during CPR, the 
potassium levels were often normal before CA. This indicates that in practice, 
if no anamnestic information about hyperkalaemia is present (history of renal 
LQVXɤFLHQF\HWFK\SHUNDODHPLDLQD32&DQDO\VLVGXULQJ&35PLJKWQRWQHFHVVDULO\
indicate the reason for CA.
Normally, 98% of the potassium in the body is in the intracellular space. The 
QRUPDO H[WUDFHOOXODU SRWDVVLXP FRQFHQWUDWLRQ LV ±PPROOZKHUHDV WKH
LQWUDFHOOXODUSRWDVVLXPFRQFHQWUDWLRQ LV±PPROO1D±.SXPSV LQ WKH
cell membranes are constantly maintaining the potassium-gradient over the cell 
PHPEUDQH&RPSURPLVHGEORRGÀRZWRWKHWLVVXHVDQGK\SR[LDGXULQJ&$
cause acidosis, which in turn causes changes in the potassium distribution probably 
by reducing the activity of the Na–K pump and elevating the extracellular potassium 
concentration (111). Hyperkalaemia during CA often indicates deranged balance 
rather than the absolute excess of potassium in the body.
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,QDSURVSHFWLYHSUHKRVSLWDOVWXG\6SLQGHOERHFNHWDOGHPRQVWUDWHGVLJQL¿FDQW
arterial acidosis within patients during ongoing CPR (33). The phenomenon is 
VXSSRUWHG E\ ¿QGLQJV LQ DQLPDO VWXGLHV  ,Q RXU H[SHULPHQWDO VWXG\ ZH
GHPRQVWUDWHWKHGLɣHUHQFHVEHWZHHQDUWHULDOYHQRXVDQG,2VDPSOHVGXULQJWKH
dynamic development of the acidosis. Lactate elevation and pH and BE decrease 
were detectable in IO samples during untreated VF, whereas the same changes were 
detectable in arterial blood only after the initiation of CPR. This is an interesting 
¿QGLQJDQGVXJJHVWVWKDW,2VDPSOHVFRXOGSURYLGHDEHWWHUHVWLPDWLRQRIWLVVXH
acidosis during CA than arterial samples. Moreover, our study demonstrated 
paradoxical alkalosis in the arterial blood during untreated VF, which has also 
EHHQVKRZQLQWKHSUHYLRXVH[SHULPHQWDOVWXGLHV
,QFRQFOXVLRQ32&YDOXHVG\QDPLFDOO\FKDQJHGXULQJ&$DQG&35DQGGLɣHUHQW
VDPSOLQJVLWHVGLɣHUHQWO\GLVSOD\WKHDFLG±EDVHEDODQFH$VGHPRQVWUDWHGE\RXU
H[SHULPHQWDOUHVXVFLWDWLRQPRGHOWKHWLPLQJRIWKHVDPSOHVDɣHFWVWKHDJUHHPHQW
RI,2VDPSOHV7KLV¿QGLQJZRXOGEHGLɤFXOWWRSURYHLQDFOLQLFDO2+&$VWXG\
because of the variation in the prehospital delays, sample collection timing and 
challenges with protocol compliancy. Animal models currently seem to be the only 
feasible way to examine the agreement between IO and conventional blood samples 
during CA and CPR in a standardised setting.
6.5 CLINICAL IMPLICATIONS
IO access has become a standard vascular access method both in prehospital 
DQGLQKRVSLWDOHPHUJHQFLHVZKHQGLɤFXOWLHVZLWKWKHFRQYHQWLRQDOPHWKRGVDUH
encountered. Even if several studies and guidelines state that IO samples can be 
used for laboratory analyses, the values should still be interpreted with caution. 
The consideration should always be related to the particular patient and the clinical 
situation. Based on our observational studies and the systematic review of the 
previous studies, it is easier to state when POC analyses of IO samples cannot be 
used. They cannot be used for analysing Hb and Hct values. Similarly, conclusions 
should not be drawn based on the potassium values from IO samples without 
considering the likely positive bias of up to 2–3 mmol/l between IO samples and 
arterial/venous samples. Excluding hyperkalaemia from a patient by using IO 
samples might be reasonable.
IO samples might be used for POC analyses for assessing the acid–base status 
or the sodium, calcium or glucose levels of the patient. Understanding that the IO 
VDPSOHLVGLɣHUHQWIURPYHQRXVDQGDUWHULDOVDPSOHVOLNHDUWHULDOEORRGLVGLɣHUHQW
from venous blood, is important. Interpretations from IO samples should be based 
on this understanding. If arterial or venous blood samples cannot be taken, IO POC 
results can be used to aid in clinical decision-making.
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6.6 LIMITATIONS
7KHPRVWLPSRUWDQWOLPLWDWLRQLVWKHLQVXɤFLHQWSRZHURIWKHVWXGLHV7KHVDPSOH
sizes in the observational studies (Studies II, III and IV) were smaller than the 
generally recommended size for method comparison studies. In the interpretation 
RI%ODQG±$OWPDQDQDO\VHVWKHELDVDORQHLVQRWDVXɤFLHQWPHDVXUHRIDJUHHPHQW
however the LOA (which describes the variance of the individual biases) and the CI 
of the LOA provide very important information. The small sample size causes large 
CIs for the bias and LOAs; this precludes us from making clear conclusions based 
on the study results to uniformly support or contradict the use of IO samples for 
GLDJQRVWLFXVH5HFRPPHQGHGVDPSOHVL]HVRI±SDWLHQWVPLJKWEHDFKLHYHG
if the samples are collected during diagnostic bone marrow aspirations; however, 
this would not provide important information of the values outside the reference 
UDQJHVRUWKHHɣHFWVRIXQVWDEOHKDHPRG\QDPLFVRQWKHDJUHHPHQW1RWHWKDWWKH
sample sizes in our studies (sample sizes of 23, 31 and 33), compared with other 
previously published studies (sample size range of 5–34), are above average.
Sample collection was not standardised in the experimental studies and might 
have resulted in pre-analytical errors. The samples were taken by professionals 
with limited training in laboratory methods. The amount of blood or bone marrow 
aspirate in the syringe varied and the dry-heparin-to-sample ratio was not constant. 
Excessive negative pressure could have been applied during the aspiration of the IO 
samples, thus causing haemolysis and hyperkalaemia. Incomplete air removal from 
the syringes might have altered the amount of gas dilution into the sample. Delays 
in sample analyses could have resulted in haemolysis, acidosis and hyperkalaemia. 
However, this represents the general conditions during prehospital blood collection 
and POC analyses, and the results from our studies are applicable to prehospital 
surroundings in general.
There is a possible selection bias within the patient sample in Study IV. Sample 
collection was performed during the routine HEMS missions without any additional 
UHVHDUFKDVVLVWDQFHDQGWKHVWDɣDOZD\VSULRULWLVHGSDWLHQWWUHDWPHQW7KHPRVW
time-critical and demanding patients were likely not included in the study because 
of the general workload. For the same reason, several values had to be excluded 
from the agreement analyses because of protocol violations mostly owing to the 
H[FHVVSUHGH¿QHGWLPHOLPLWEHWZHHQ,2DQGDUWHULDOVDPSOHV7KHVWULFWLQFOXVLRQ
criteria of patients requiring an IO access and POC laboratory analyses for treatment 
prolonged the recruitment period. Because of ethical reasons, opening an IO access 
RQO\IRUWDNLQJVWXG\VDPSOHVZDVQRWDOORZHG7KHFDOFXODWHGVDPSOHVL]HZDV
patients; therefore, we collected samples from 35 patients to cover the possible 
PLVVLQJGDWD7KH¿QDOQXPEHURISDLUHGPHDVXUHPHQWVIRUWKHDJUHHPHQWDQDO\VHV
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UHPDLQHGXQGHURZLQJWRZLWKGUDZDORIFRQVHQWVSURWRFROYLRODWLRQVDQGIDLOHG
analyses.
6.7 FUTURE DIRECTIONS
,GHDOO\WKHPHWKRGRI32&DQDO\VLVRI,2VDPSOHVFRXOGEHYDOLGDWHGDQGVSHFL¿F
UHIHUHQFHYDOXHVFRXOGEHVHWIRUGLɣHUHQWSDUDPHWHUV'LɣHUHQWPDQXIDFWXUHUV¶32&
GHYLFHVVKRXOGEHFRPSDUHGWRGHWHUPLQHDQ\GLɣHUHQFHVLQWKHLUSHUIRUPDQFH7KH
validation studies should be based on proper sample size calculations and should 
include several hundred paired measurements, which is very challenging owing to 
ethical and consent issues and needs multi-centre studies to be achievable.
Blood typing and crossmatching from the IO samples are feasible and reliable 
within hospital patients undergoing diagnostic bone marrow aspirations (88,89). 
A prehospital transfusion protocol is present in many EMS systems, including 
drawing a crossmatch sample before the transfusion of O-negative red blood cells. 
If the patient is so hypovolemic that venous access cannot be achieved, drawing 
the crossmatch sample from the IO access would be very useful. A study on the 
feasibility and reliability of blood typing and crossmatching from prehospital IO 
VDPSOHVVKRXOGEHSHUIRUPHGWRYDOLGDWHWKHPHWKRGDQGFRQ¿UPWKHUHVXOWVRI
in-hospital patient material.
The evidence supporting the laboratory screening of the reversible causes of 
CA is very limited. It is not completely evident what the electrolyte and acid–base 
YDOXHVWDNHQGXULQJ&35LQGLFDWHDQGKRZGRWKH\UHÀHFWWKHSUHDUUHVWVWDWH%DVHG
on our experimental study, the elevated potassium levels during CPR, compared to 
the pre-arrest state, involve a risk of false positive diagnoses of hyperkalaemia as a 
cause of the CA. More evidence is required about the reliability and consequences 
of the laboratory analyses during CPR and whether the correction of electrolyte 
GLVRUGHUVDɣHFWVRXWFRPH
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7 CONCLUSIONS
The conclusions of this doctoral dissertation are as follows:
 3UHYLRXVVFLHQWL¿FHYLGHQFHFRQFHUQLQJWKHDQDO\VLVRI ,2VDPSOHV LVVFDUFH
and it is based on 27 studies with heterogenic populations and small sample 
sizes. Majority of the subjects have been animals or haemodynamically stable 
humans. Only one previous study has been performed in a critically ill human 
population. Recommended statistical methods for method comparison studies 
were used only in three of these studies.
2. The analyses of IO samples using an i-STAT® POC analyser are generally feasible 
in young people. The method might not be applicable to older patients owing 
to the gradual increase in the adiposity of the bone marrow with age.
3. Drawing waste blood before obtaining the actual sample does not bring any 
EHQH¿W
4. POC analysis of IO samples can be used for supporting decision-making in 
critical care as long as its limitations are recognised. Providing unambiguous 
interpretations about the acceptable agreement between IO samples and arterial/
venous samples is not possible because the tolerance to bias and precision 
GHSHQGVRQWKHFOLQLFDOFRQWH[WDQGVSHFL¿FSDUDPHWHU7KHDJUHHPHQWEHWZHHQ
WKH32&UHVXOWVIURP,2DQGDUWHULDOVDPSOHVYDULHVIRUGLɣHUHQWSDUDPHWHUV
KRZHYHUWKHIROORZLQJJHQHUDO¿QGLQJVFDQEHVWDWHG
• Potassium values from IO samples are generally higher than those from 
arterial and venous samples.
• pO2 and pCO2 values from IO samples resemble those from venous samples.
• Hb and Hct values from IO samples do not agree with those from arterial 
and venous samples and should not be used.
• Glucose and lactate values form IO samples agree with those from arterial 
and venous samples during normal circulation. During CA, IO glucose values 
resemble the pre-arrest state, whereas hyperglycaemia is detected in arterial 
and venous blood. Elevated lactate levels are noticed in IO samples during 
untreated VF; however, in arterial and venous samples, they are detected 
only after the initiation of CPR.
 1DDQGL&DKDYHFOLQLFDOO\VXɤFLHQWDJUHHPHQWZLWKDUWHULDODQGYHQRXV
samples.

CONCLUSIONS
• pH, BE and HCO3 measurements from IO samples agree relatively well 
with those from arterial and venous samples, except during CA, when tissue 
DFLGRVLVGHYHORSVGLɣHUHQWO\LQGLɣHUHQWEORRGFRPSDUWPHQWV
5. The POC laboratory values dynamically change during CA and CPR. The 
following remarks about how the IO, arterial and venous samples during CPR 
UHÀHFWWKHSUHDUUHVWVWDWHFDQEHSRLQWHGRXW
• Potassium values taken during CPR are higher than pre-arrest values in the 
venous, arterial and IO samples, leading to a risk of false interpretation of 
hyperkalaemia as a cause of the CA.
• Developing acidaemia during CA is detectable in IO samples during untreated 
VF but in arterial samples only after the initiation of CPR.
• During CPR, the lactate, pH, Na and iCa values from IO samples are similar 
to those from arterial and venous samples; thus providing an alternative to 
arterial and venous samples.
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